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OPA1 is a 120kDa large GTPase belonging to the dynamin superfamily. It is the only 
known mitochondrial inner membrane fusion protein, mediating fusion of the mitochondrial inner 
membranes following outer membrane fusion. Additionally, OPA1 also regulates cristae 
morphology and maintains respiratory chain function.  
OPA1 has two forms—inner-membrane-anchored long forms (l-OPA1) and cleaved inter-
membrane-space only short forms (s-OPA1). L-OPA1 are proteolytically processed by two 
mitochondrial proteases—OMA1 and YME1L, acting at cleavage sites S1 and S2 respectively, to 
produce s-OPA1.  
In both mice and human, half of the mRNA splice forms of Opa1 are constitutively 
processed post translation to yield exclusively s-OPA1. However, the specific function of s-OPA1 
in mitochondrial fusion has been debated—under basal conditions, s-OPA1 are needed to maintain 
optimal fusion activity, but in certain stress conditions, s-OPA1 is dispensable for fusion. By 
constructing cells in which the Opa1 locus no longer produces transcripts with S2 cleavage sites 
using CRISPR-Cas9, we generated a simplified system to identify the novel YME1L-dependent 
site S3 that mediates constitutive and complete cleavage of OPA1. We found that S3 site locates 
within the C-terminal leucine string of Opa1 exon4b, slightly upstream of the well-established S1. 
We show that mitochondrial morphology is highly sensitive to the ratio of l-OPA1 to s-OPA1, 
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The mitochondrion is an organelle of bacterial ancestry, originating from within the 
bacterial phylum α-Proteobacteria (Alphaproteobacteria). The well-known endosymbiotic 
hypothesis states that the first mitochondrion evolved from a bacterial progenitor via symbiosis 
with a proto-eukaryotic host cell. The strongest evidence for this hypothesis comes from 
phylogenetic gene analysis, including both mitochondrial DNAs and ribosomal RNAs, which 
show homology to the α-Proteobacteria. The mitochondrial genome contains in total 37 genes. 
13 of the 37 genes encode proteins; 2 encode ribosomal RNAs; and 22 encode transfer RNAs. 
All of the 37 genes are essential for OXPHOS activity and high levels of mtDNA mutations 
generally result in impaired energy generation (Carelli and Chan, 2014). Yet mitochondrial 
genome evolution has taken radically different pathways in diverse eukaryotic lineages, and the 
organelle itself is increasingly viewed as a genetic and functional mosaic, with the bulk of the 
mitochondrial proteome having an evolutionary origin outside Alphaproteobacteria. The vast 
majority of the ∼1,000 proteins of the mitochondrial proteome are encoded in the nuclear 
genome, synthesized in the cytosol, and imported into the organelle via rigorous importing 
systems on mitochondrial membranes.  
Mitochondria fulfill several essential functions in eukaryotic cells. Long been described 
as the powerhouses for generating ATP via oxidative phosphorylation, they also play a central 
role in Ca2+ signaling, lipids metabolism, apoptosis and innate immunity. They can also produce 
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damaging metabolic byproducts such as ammonia and reactive oxygen species (ROS) 
sequestration (Chan, 2020). In addition, mitochondria are now understood to play active roles in 
integrating signaling pathways and responses to stressors (Focusing on mitochondrial form and 
function, 2018). Due to these significant physiological functions, with a few exceptions, 
mitochondria are found in all eukaryotic cells with varying numbers per cell among different 
organisms and tissue types. In mammals, except for mature human erythrocytes, mitochondria 
are utilized by every single cell to meet the varying energetic demands of a specific tissue, 
ranging from ~80 to ~2000 per cell (Cole, 2016). These demands are great in tissues such as the 
heart and brain, where a dysfunction of mitochondria has been associated with an increasing 
number of human diseases. Mitochondrial activity must therefore be tightly monitored and 
optimized to meet any changes in cellular metabolism and physiology.  
 
Structure of mitochondria 
Mitochondria are double-membrane organelles. The outer membrane (OM) is a lipid 
bilayer membrane separating mitochondria compartments apart from the cytosol. The OM is 
porous and freely traversed by ions and small, uncharged molecules through pore-forming 
membrane proteins (porins), such as the voltage-dependent anion channel VDAC (Bayrhuber et 
al., 2008). Any larger molecules, especially proteins, have to be imported by special 
translocases. Because of its porosity, there is no membrane potential across the outer membrane.  
In contrast, the inner membrane is a tight diffusion barrier to all ions and molecules. 
Substrates waiting to get inside the mitochondrial matrix can only get across in the presence of 
corresponding membrane transport proteins, each of which is selective for a particular ion or 
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molecule. As a result of the ion selectivity of the inner membrane, an electrochemical membrane 
potential of about 180 mV builds up across the inner mitochondrial membrane (Kühlbrandt, 
2015). Oxidative phosphorylation (OXPHOS) takes place on the inner membrane through a 
series of biochemical processes in the respiratory complexes. More specifically, in a chain of 
membrane protein complexes, electrons are transferred across different compartments and 
protons get pumped out into the inter membrane space, creating the electrochemical gradient 
across the inner membrane and to the ATP synthase. One of the most functionally important part 
of the IM is the cristae (Fig 1.1), the invaginated membrane harboring membrane proteins, such 
as the electron transport chain (ETC) complexes. Cristae can be lamellar, likely formed by 
infoldings of the IM sheet, or tubular (Riva et al., 2005; Hoppel et al., 2009). The intra-cristal 
space (ICS) is the inside space of lamellar or tubular cristae, continuous with the IMS; however, 
the functional continuity is thought to be limited by the narrow cristae junction (CJ) structure. 
The rest of the IM that runs parallel with the OM is the inner boundary membrane (IBM). Recent 
studies have shown that the cristae structure is also dynamically regulated and constantly re-
modeled within individual mitochondria, with the functional regulation of MICOS complex 
(Kondadi et al., 2020).  
 
Mitochondrial Dynamics 
How do cells maintain their healthy mitochondrial networks? One of the fundamental 
ways is through the versatile regulation mechanisms of mitochondrial morphology and 
dynamics. The term mitochondrial dynamics encompasses the processes of mitochondrial fusion, 
fission, turnover, and transport.  
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Mitochondria are remarkably dynamic organelles. Individual mitochondria can have a 
variety of morphologies, appearing as small spheres, short or long tubules, or interconnected 
tubules. These morphologies are controlled by the opposing processes of fusion and fission. 
More specifically, during fusion events, two or more mitochondria fuse together into rods or 
chains and further threads, which later may form a connected network. During fission events, a 
part of tubular mitochondria gets constricted and later divide into two or more smaller 
mitochondria spheres. As discussed previously, mitochondria have dual membranes; therefore, 
mitochondrial membrane dynamics is a complicated multistep process that requires the 
coordinated regulation of protein and lipid molecules on both membranes. A fibroblast can have 
a population of dozens to hundreds of mitochondria, each containing at least one mtDNA 
genome.  
Mitochondria Transport and Turnover  
Mitochondria are distributed across the cell through cytoskeletons, most times along 
microtubules in mammalian cells. There is a well-designed transport machinery involving 
various protein motors and adaptors responsible for anchoring and moving mitochondria along 
the microtubule tracks. Due to the special shape of neurons and the need to transport 
mitochondria across neuronal axons and dendrites, mitochondria trafficking has been especially 
widely studied in neurons. Trafficking of mitochondria is bi-directional—anterograde transport 
towards microtubule plus end from cell soma to dendrites and axons, and retrograde transport 
towards microtubule minus end from synapses/dendrites back to soma. First discovered in 
Drosophila, two different motor proteins are used in the opposing transport systems—
anterograde transport utilizing Kinesin-1 and retrograde transport utilizing Dynein (Pilling et al., 
2006). The attachment of microtubule motor proteins to mitochondria is mediated by 
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mitochondrial outer membrane proteins RhoT (small Rho GTPase, in mammalian cells being 
Miro1/2) and their motor adaptors Trak1 and Trak2 (Stowers et al., 2002; Glater et al., 2006; 
Russo et al., 2009).  
Another dynamic aspect of mitochondria is the selective removal of dysfunctional 
mitochondria via autophagy, a quality-control mechanism named mitophagy that ensures a 
healthy mitochondrial population. Mitophagy in conjunction with mitochondrial biogenesis 
regulates the mitochondrial content that is needed under various conditions to meet cellular 
metabolic demand. Several key factors and pathways have been identified in regulating 
mitophagy and the most well-known pathways include the Pink1/Parkin pathway and Nix 
pathway. Mitophagy consista in the sequestration of the defective organelle into a double 
membrane phagosome that is later fused with lysosomes forming autolysosomes, where the 
contents are degraded and can be recycled. 
The turnover rate varies depending on different species, cell types, and physiological 
conditions within single cells. It has been estimated that the turnover of mitochondria in both 
young and aged rat liver, heart, and brain is 9.3, 17.5, and 24.4 days, respectively (Menzies and 
Gold, 1971).  
 
Mitochondrial Fission 
Mitochondrial fission is a multi-step process where the recruitment of the large GTPase 
Drp1 plays a crucial role. Drp1 is evolutionary conserved across Caenorhabditis elegans 
(Labrousse et al., 1999), yeast (Bleazard et al., 1999), and mammals (Smirnova et al., 2001). It is 
mainly a cytosolic protein, but is dynamically recruited to mitochondrial and peroxisomal 
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membranes, where it oligomerizes and drives membrane constriction in a GTP-dependent 
manner (Tilokani et al., 2018). Genetic ablation of Drp1 leads to a drastic elongation of both 
mitochondria and peroxisomes (Koch et al., 2003) in multiple cell lines and a variety of animal 
models (Ishihara et al., 2009).  
During mitochondrial fission, Drp1 is recruited from the cytosol to the mitochondrial 
outer membrane, where it forms a ring-like structure around the mitochondria leading to the 
narrowing of the membrane (Smirnova et al., 2001; Fröhlich et al., 2013). Then, GTP hydrolysis 
enhances this membrane constriction (Mears et al., 2011) which marks a potential future site of 
mitochondrial scission.  
As Drp1 lacks a Pleckstrin Homology (PH) domain to bind membrane phospholipids 
directly, additional adaptor proteins are needed to help the recruitment of Drp1 onto the outer 
membrane (Tilokani et al., 2018). In mammalian cells, three adaptor proteins have been 
identified serving as the receptor proteins of Drp1--the tail-anchored proteins mitochondrial 
fission factor (MFF) (Gandre-Babbe and van der Bliek, 2008) and mitochondrial dynamics 
proteins 49 and 51 (MiD49 and MiD51) (Palmer et al., 2011; Losón et al., 2013). Although both 
MFF and MiDs serve as the receptor protein of Drp1, their roles differ slightly in regulating Drp-
1 mediated fission, which leads to different mitochondrial morphology outcomes in cell lines 
with either MFF or MiDs knocked out.  Overexpression of MFF leads to a fragmented network 
whereas MFF knockout induces mitochondrial and peroxisome elongation (Otera et al., 2010), 
accompanied by a decrease in Drp1 mitochondrial recruitment. However, MiD49 and MiD51 
mutants show completely opposite phenotypes. Overexpression of MiDs leads to mitochondrial 
elongation due to Drp1 sequestration (Palmer et al., 2011; Zhao et al., 2011). Either Mid49 or 
MiD51 can mediate Drp1 recruitment and mitochondrial fission in the absence of Mff, 
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suggesting that multiple receptors can recruit Drp1 to mitochondria for fission independent of 
each other (Losón et al., 2013). 
In addition to Drp1 regulated mitochondrial membrane constriction step, it has been 
found that ER is required for the initiation of the mitochondrial division (Friedman et al., 2011). 
The pre-constriction step at the ER-mitochondria contact site is thought to mark the future fission 
site and decrease the average mitochondrial diameter from approximately 300–500 nm to ~150 
nm, further allowing Drp1-oligomeric ring formation (Friedman et al., 2011). Drp1 and its 
adaptor proteins are subsequently recruited to these mitochondria–ER contact sites prior to 
mitochondrial division (Friedman et al., 2011). Furthermore, recent studies suggest that the 
canonical GTPase Dnm2, which was known to regulate endocytic vesicle fission, was involved 
in catalyzing the final step of membrane scission (Lee et al., 2016) to facilitate the complete 
separation of mitochondria. However, another  study suggests that Dnm2 is not involved in 
fission after all, and it is DRP1 that is crucial to the final fission step (Fonseca et al., 2019). 
Debates remain in the field as to determine the actual role of Dnm2 in mitochondrial fission 
process, if any.  
 
Mitochondrial Fusion 
Mitochondrial fusion is the merger of two individual mitochondria into a new 
mitochondrion. One of the most important and well known functions of fusion is to regulate 
mitochondrial morphology. Each cell type has a characteristic profile of mitochondrial 
morphology that is maintained by the balanced control of mitochondrial fusion and fission. For 
instance, interphase fibroblast cells in culture typically have tubular mitochondria, ranging from 
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short tubules to long tubules to interconnected tubular networks. When fusion is blocked, the 
tubules fragment rapidly into small spheres as a result of unopposed fission (Chen et al., 2003a). 
When fission is blocked, the tubules elongate dramatically and show more interconnections due 
to unopposed fusion. Imbalance between fusion and fission is related with the onset and 
progression of several familial and sporadic neurodegenerative disorders (Knott and Bossy-
Wetzel, 2008).  Despite the importance of fusion and fission balance control, little is known 
about how cells maintain a particular balance between fusion and fission events. In one study, 
researchers have shown that fission events often occur shortly after fusion events, suggesting that 
there may be an underlying feedback mechanism linking the two processes (Twig et al., 2008).  
Two major categories of fusion have been studied so far: the full complete fusion and the 
‘kiss and run’ type of fusion. In a typical mitochondrial fusion reaction, two mitochondria come 
into contact end-to-end (longitudinal interaction) or side-by-side (oblique interaction), and the 
membrane fusion event occurs at the contact site. In addition to two or more mitochondria fusing 
into one, fusion can also refer to single mitochondrion fusing from one end to the other, forming 
the ring-like donut shape structure. Since mitochondria are double-membraned organelles, one 
complete fusion process consists of an outer membrane fusion followed by an inner membrane 
fusion. These two membrane fusion events occur close in time, but are spatially and temporally 
separable (Song et al., 2009). The end result of membrane fusion is content mixing, with the 
matrix components diffusing throughout the new mitochondrion.  
Besides the obviously complete and relatively prolonged fusion events, some fusion 
events called ‘kiss-and-run’ fusion, are extremely transient, and the original mitochondria 
quickly separate after content exchange, with no obvious structural rearrangement (Liu et al., 
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2009). It has been found that mitochondria moving along the same microtubule usually undergo 
the complete fusion whereas mitochondria traveling along distinct but spatially close 
microtubules go through the transient (‘kiss-and-run’) fusions. Cultured rat cardiomyocytes 
expressing photoactivatable fluorescent proteins targeted to the mitochondrial matrix together 
with another mitochondrial fluorescent protein were used to observe such events. When 
individual mitochondria were laser photo-activated, the fluorescence marked mitochondria 
exchange matrix contents with other mitochondria during transient encounters as shown by 
mixing of converted fluorescence. However, since the fusion events are so transient, only content 
mixing were observed without obvious morphology change on either mitochondrion (Liu et al., 
2009). A basic difference between transient fusion and complete fusion lies in the extent of the 
mixing of the mitochondrial components. The restricted mixing of integral membrane 
components during transient fusion may be of relevance for preservation of the original 
morphology of the merging organelles (Liu et al., 2009). The observation of this flexible 
transient fusion type implies that fusion pores can rapidly open and close between two 
mitochondria, further suggesting that besides regulating mitochondrial morphology, content 
exchange is also an important function of mitochondrial fusion (Chan, 2020).  
Although mtDNA is located in the matrix and content exchange happens during fusion 
events, mixing of mtDNA genomes during fusion were not obviously observed. A previous study 
showed that when two different cell lines harboring distinct non-overlapping mtDNA deletions 
fuse together, the two sets of mtDNA functionally complemented each other and together 
restored the normal level of protein synthesis, however, the two sets of mtDNAs remained in 
discrete nucleoids without obvious intermixing. The result suggests that during mitochondrial 
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fusion, the nucleoids regulate and maintain their genetic content instead of freely exchange 
mtDNA components among each other (Gilkerson et al., 2008).  
In mammalian cells, three large GTPases, which bind to GTP and hydrolyze GTP to GDP 
to facilitate various biochemical processes, are discovered to be essential for mitochondrial 
fusion. The mitofusins Mfn1 and Mfn2 are transmembrane GTPases embedded in the 
mitochondrial outer membrane. They face the cytosol and are responsible for mediating 
mitochondrial outer membrane fusion (Rojo et al., 2002; Santel and Fuller, 2001). OPA1 has 
multiple isoforms, some anchored on the mitochondrial inner membrane and others lacking a 
transmembrane anchor (Delettre et al., 2000a). It mediates inner membrane fusion. Depletion of 
any of these three GTPases results in severely reduced levels of mitochondrial fusion (Chen et 
al., 2005b; Cipolat et al., 2004; Griparic et al., 2007a; Song et al., 2007a).  
Molecular Machinery of Mitochondrial Fusion 
Outer Membrane Fusion (MFN1&2) 
The mitofusins were the first proteins found to be important for mitochondrial fusion. 
The first mitofusin gene, fuzzy onions (fzo), was discovered in Drosophila, the deletion of which 
leads to male infertility (Hales and Fuller, 1997). The gene also has homologs in mammals, 
nematodes and yeast, and later studies have shown that the fusion functions are conserved across 
these species. In early post-meiotic spermatids, all mitochondria aggregate beside each haploid 
nucleus, then fuse into two giant mitochondria that wrap around each other to form a spherical 
structure named the Nebenkern. When viewed in cross section by transmission electron 
microscopy (TEM), the Nebenkern resembles an onion slice, and therefore early round 
spermatids are also known as the ‘onion stage’. In fzo mutants, the Nebenkern structure 
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formation was disrupted, and in TEM images, instead of having round onion slices, they are 
irregular and ‘fluffy’ and ‘fuzzy’, giving the gene the name ‘fuzzy onions’. Imaging studies 
showed that mutation of Fzo resulted in failure of the mitochondria to fuse. It appears that Fzo 
function is restricted to spermatids during a brief developmental stage in spermatogenesis. A 
homologous gene, Marf/Dmfn, has been found to be expressed more widely and function more 
broadly to mediate mitochondrial fusion in other tissues (Hwa et al., 2002).  
Mammalian cells have two mitofusins, Mfn1 and Mfn2, that are anchored on the 
mitochondrial outer membrane. Deletion of either Mfn11 or Mfn2 leads to fragmented 
mitochondria, due to unopposed Drp1-mediated fission. Conversely, overexpression of Mfn1 or 
Mfn2 leads to highly tubulated mitochondria, an indication of elevated fusion (Rojo et al., 2002; 
Santel and Fuller, 2001). Knockout mouse models further demonstrate the essential roles of these 
proteins for mitochondrial fusion as well as other vital functions (Chen et al., 2003a, 2005b). 
Homozygous Mfn1 and Mfn2 knockouts are embryonically lethal, suggesting that Mfn1 and 
Mfn2 are both required for embryonic development, and may have a cooperative relationship in 
the early stage of embryogenesis. Mouse embryonic fibroblasts (MEFs) lacking either Mfn1 or 
Mfn2 have highly fragmented mitochondria compared to the tubular network observed in wild-
type cells. Fusion assays indeed indicate a great reduction in the levels of mitochondrial fusion in 
single knockout MEFs (Chen et al., 2003a) and a complete loss of fusion in cells lacking both 
Mfn1 and Mfn2 (Chen et al., 2005b).  
When mitochondrial fusion rates are reduced, the mitochondrial population fragments 
into short tubules or small spheres because of ongoing mitochondrial fission in the face of less 
fusion. These observations support the idea that mitochondrial morphology is dictated by a 
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balance between fusion and fission, and although there are some interplay between these two 
processes.  Although both have been shown to be required for mediating mitochondrial fusion, it 
has also been reported that Mfn1 and Mfn2 have distinct functions. In mouse models, only Mfn2 
mutant mice show placental defects and Mfn1 mutant embryos display completely normal 
placental development. Mfn1 tethers mitochondrial membranes, depending on GTP hydrolysis, 
with a higher efficiency than Mfn2, which corresponds to changes in the oligomeric states of the 
Mfn-containing complex. These properties reflect differences in the GTPase activity of the Mfn 
proteins; purified Mfn1 exhibited ∼eightfold higher activity than Mfn2 (Ishihara et al., 2004). In 
addition to mitochondrial fusion, Mfn2 has been implicated in maintaining the sites of contact 
between the mitochondria and the endoplasmic reticulum (de Brito and Scorrano, 2008).  
 
Inner Membrane Fusion (OPA1) 
Inner membrane fusion is mediated by Optic Atrophy 1 (Opa1), a large GTPase of the 
dynamin superfamily. Going from N-terminus towards the C-terminus, the protein has a 
mitochondrial targeting sequence, a transmembrane domain, a coiled coil domain and other 
functional domains (GTPase domain, middle domain, and GTPase effector domain). Opa1 was 
first identified as the gene mutated in autosomal dominant optic atrophy, a human disease 
showing progressive loss of visual acuity, and bilateral temporal atrophy of the optic nerve with 
an early onset within the first two decades of life (Alexander et al., 2000b).  
 
Cells lacking Opa1 show mitochondrial outer membrane fusion, but the fusion process 
cannot proceed further into sequential inner membrane fusion, resulting in fragmented 
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mitochondria in Opa1-null cells (Song et al, 2007). Unlike mitofusins, Opa1 is needed on only 
one of two opposing mitochondria for inner membrane fusion to occur (Song et al., 2007a, 2009; 
Ban et al., 2017a).  
 
Opa1 is post-translationally regulated by proteases 
 
In human cells, eight RNA splice forms of Opa1 are generated from alternative splicing 
of exons 4, 4b, and 5b (Fig 1.2). All RNA splice forms contain an N-terminal mitochondrial 
targeting sequence (MTS). The MTS is removed by the matrix processing protease (MPP) during 
import into the mitochondrial matrix, leaving a very short fragment remaining in the matrix and 
the transmembrane segment anchoring OPA1 on the inner membrane, whereas the majority of 
OPA1 is in the intermembrane space. At least two proteolytic cleavage sites are present in the 
intermembrane space segment of Opa1, enabling membrane-anchored long form of OPA1 (l-
OPA1) to be further cleaved by proteases, leading to the generation of short forms of OPA1 (s-
OPA1) lacking the N-terminal transmembrane domain. The universal exon 5, which is present in 
all isoforms, encodes a proteolytic processing site S1. When S1 site gets recognized and cleaved 
by OMA1, a mitochondrial inner membrane metalloprotease, partial OPA1 long forms get 
processed into short forms, which do not have a membrane anchor and only exist in the 
intermembrane space. The short forms are soluble in principle, but known to form complexes 
with the membrane-bound long Opa1 isoforms to modulate fusion activity. Additional 
proteolytic cleavage site, S2, is found in half of the splice forms (4, 6, 7, and 8), which is 
encoded by the exon 5b and cleaved by YME1L, an m-AAA protease (Song et al., 2007a). The 
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OMA1 and YME1L proteases together regulate OPA1 processing (Song et al., 2007a; Anand et 
al., 2014a).  
 
The role of Opa1 isoforms in mediating fusion 
 
An intriguing question is why this diversity of proteolytic processing of OPA1 exists. It 
has been shown recently that both the long and short OPA1 isoforms can independently restore 
mtDNA content, maintain respiratory function, stabilize OXPHOS complex, and maintain 
energetic activity (Lee et al., 2017)(Del Dotto et al., 2017b). However, there are controversial 
opinions on their significance to fusion activity. It is clear that, under basal conditions, a 
combination of both long and short isoforms is required for physiological levels of mitochondrial 
fusion (Song et al., 2007a). For example, when expressing either long or only short OPA1in 
Opa1-null cells, little mitochondrial fusion is detected. When both isoforms are co-expressed, 
partial fusion activity is restored in the cells (Song et al., 2007a). Under pathological conditions, 
such as dissipation of mitochondrial inner membrane potential, Oma1 is activated and promotes 
complete processing of OPA1 to short isoforms (Griparic et al., 2007a; Mishra et al., 2014a). 
This complete shift to short isoforms results in inactivation of fusion activity. It has also been 
proposed that long and short Opa1 serve completely opposite roles in mitochondrial dynamics—
long OPA1 alone is sufficient for mediating fusion whereas short Opa1 promotes fission. S-
OPA1 accumulation has been linked to mitochondrial fragmentation in Yme1L null MEFs, 
where an increased level of short Opa1 has been observed due to OMA1 activation induced 
increased cleavage. Also, when expressing s-OPA1 in Oma1/Yme1L DKO MEFs, the 
mitochondria network became more fragmented compared to control. However, it should be 
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noted that several studies have shown that increased levels of overall OPAl proteins, regardless 
of l- or s-OPA1, can cause mitochondrial fragmentation, therefore this could be an artifact 
induced by total OPAl protein levels instead of s-Opa1.  
 
Several lines of evidence indicate that long OPA1 by itself is capable of mediating 
mitochondrial fusion under certain conditions. In Opa1-null cells expressing only long OPA1 
isoforms, there is extensive elongation of mitochondria if the cells are treated with 
cycloheximide, a protein translation inhibitor which induces a condition called stress-induced 
hyperfusion (Tondera et al., 2009a). Additionally, cells with both the Oma1 and Yme1L 
proteases knocked out, where OPA1 cannot be processed into the short forms, contain some 
tubular mitochondria and mitochondrial fusion activity (Anand et al., 2014a). Lastly, in a recent 
study, the authors developed an in vitro assay where recombinant long Opa1 isoforms 
incorporated into liposome membranes showed fusion activity against other liposomes, as long 
as the opposing liposomes contained cardiolipin, a vital lipid component on the inner membrane 
and known to be a binding partner of OPA1 (Ban et al., 2017a). However, the study also showed 
evidence that short OPA1 can modulate fusion where adding s-OPA1 into l-OPA1 plus liposome 
system can enhance fusion activity (Ban et al., 2017a). Even more, short OPA1 alone mediates 
GTP-dependent fusion when added to liposomes containing cardiolipin (Ban et al., 2018b).  
Taken together, these results indicate that both the long and short forms of Opa1 can 
display inherent fusion activity. In cells under basal conditions, long or short OPA1 alone shows 
little or no fusion activity (Song et al., 2007a). Under stress conditions, especially conditions 
associated with stress-induced hyperfusion (Tondera et al., 2009a), the fusion activity of the long 
isoform is activated by unknown mechanisms, which could potentially be explained by 
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temporary structural change or enhanced activity binding to cardiolipin. Short Opa1 can 
substantially regulate the fusion activity of long Opa1 (Ban et al., 2017a, 2018b), and in fact, 
cleavage of long Opa1 into the short isoform activates its membrane fusion activity (Mishra et 
al., 2014a).  
The role of Opa1 in cristae maintenance and energetics 
In addition to its inner membrane fusion function, depletion of OPA1 protein in cells 
leads to increased apoptotic sensitivity and decreased mtDNA content and stability, as well as 
reduced energetic activity. These are correlated with the change in cristae structure, including 
cristae number, shape, and cristae junction tightness. Oligomerization of OPA1 appears to be a 
mechanism that regulates apoptosis by maintaining the tightness of cristae junctions (Frezza et 
al., 2006).  
The apoptosis regulation function of OPA1 was discovered in a study where the authors 
suggest that under normal conditions, OPA1 protein oligomerized to keep the cristae junction 
tight, whereas during tBid-induced apoptosis, OPA1 complexes got disrupted and the cristae 
junctions widened, allowing for the release of cytochrome c from the intra-cristal space (Frezza 
et al., 2006). This cristae junction widening was not seen in other studies, and in fact some 
studies showed contrary phenotypes in which during apoptosis, the cristae junctions became 
tighter and narrower (Yamaguchi et al., 2008; Sun et al., 2007). Further research is needed to 
confirm this cristae junction change phenotype and the role of Opa1 in regulating this phenotype 
under stress induced apoptosis. Despite contradictory results on the cristae junction morphology, 
past studies showed consistently that OPA1 complex disassembly is necessary for cytochrome c 
release during apoptosis (Frezza et al., 2006; Yamaguchi et al., 2008). Therefore, it is more 
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likely that the assembled OPA1 complex instead of cristae junction wideness/morphology is the 
key regulator of apoptosis induced cytochrome c release, pointing to a functional link between 
OPA1 and cytochrome c.  
Through the immuno-EM images of OPA1 within mitochondria, it is obvious that OPA1 
is enriched along the central neck area of the cristae with gradual decreases toward cristae 
junction and tip (Barrera et al., 2016). The most striking ultrastructural defect in OPA1 
deficiency is the disruption of cristae structure, showing greatly decreased cristae number and the 
loss of cristae tightness (Olichon et al., 2003; Griparic et al., 2007a; Lee et al., 2017a). OPA1 
deficiency causes defects in respiration and the respiratory complex, likely due to the loss 
membrane in which respiratory complexes and super-complexes assemble (Lee et al., 2017a; Del 
Dotto et al., 2017b). It is likely that the functions of OPA1 in energetic maintenance and 
apoptotic resistance are attributed to the structural and maintaining cristae tightness (Cogliati et 
al., 2013). 
Two recent studies have demonstrated the important role of s-OPA1 in energetic 
maintenance (Lee et al., 2017a; Del Dotto et al., 2017b). Different isoforms were put back into 
the Opa1 null cells and studied individually. In contrast to the prevalent notion that s-OPA1 is 
just the nonfunctional proteolytic product, it was found that s-OPA1 by itself is sufficient to 
maintain respiratory function independent of l-OPA1 (Lee et al., 2017a; Del Dotto et al., 2017b). 
The expression of a single form of S1-cleaved s-OPA1 in OPA1-KO cells was able to maintain 
mtDNA stability, respiratory complexes, and cristae structure, indistinguishable from that of L-
OPA1 (Lee et al., 2017a). No functional distinction among the eight variants were found in 
restoring energetic activity (Del Dotto et al., 2017b). Importantly, the ability of s-Opa1 alone for 
maintaining energetic function without being able to directly mediate fusion supports the 
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previous idea that the fusion function and cristae maintenance and energetics function of OPA1 
are mechanistically separated (Frezza et al., 2006). The energetic phenotypes of OPA1 
deficiency include respiration defects, decreased levels of respiratory complexes and mtDNA 
content, all of which are likely due to the lack of adequate cristae structure maintenance in the 
absence of OPA1. Cristae membranes are the assembly platform for respiratory complexes, and 
therefore, when cristae structures change or cristae numbers decrease, respiratory complexes 
become unstable and degraded, which later could deteriorate into a respiration defect.  
Opa1 knockout cells show an almost complete loss of cristae structure, suggesting the 
importance of Opa1 in cristae maintenance. It was shown in one study that the expression of 
either l- or s-OPA1 increased the cristae number, indicating that either isoform is able to 
maintain cristae structure independent of fusion activity. Moreover, OPA1 mutants with 
defective GTPase domain can rescue the number of cristae, but with an abnormal morphology. 
The cristae in Opa1 null cells infected with Opa1 GTPase mutants were swollen and round 
(balloon shape), indicating a loss of cristae tightness (Lee et al., 2017a).  
In Opa1 mutant cells and mice, mtDNA levels are dramatically decreased (Elachouri et 
al., 2011; Chen et al., 2010). The role of Opa1 in mtDNA maintenance is thought to be linked to 
the fusion activity (Chen et al., 2010; Patten et al., 2014). However, since mtDNA is attached to 
the IM, the mtDNA decrease with OPA1 deficiency may also be due to the cristae and inner 
membrane disruption. The two studies on s-Opa1 function show that short Opa1 can also rescue 
mtDNA level, regardless of the minimal ability for fusion (Lee et al., 2017a; Del Dotto et al., 
2017b). The new finding that s-OPA1 alone, without l-OPA1, is able to support the formation of 
cristae, as well as the maintenance of cristae tightness, is unexpected but significant, as it 
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prompts the revision of the current paradigm of l- and s-OPA1 functions.  
Physiological roles of mitochondrial fusion 
We will be discussing some key functions of mitochondrial fusion and fission in the next 
section. Fusion and fission fulfill important physiological functions for the mitochondria. 
Knockout mouse models of any fusion genes result in embryonic lethality, further indicating the 
vital roles of fusion process in maintaining mitochondrial and cellular functions. Next, we will 
briefly discuss the known roles of fusion and how they are physiologically linked with various 
cellular processes. The functions of mitochondrial dynamics are still not fully understood and 
researchers are actively looking for additional aspects that fusion and fission have in regulating 
mitochondrial and cellular functions. Here, we mainly talk about five well studied functions on 
the list-- 
 
Mitochondrial Morphology Regulation 
 
The balance of fusion and fission appears to be essential for controlling the size, shape, 
and abundance of mitochondria within a given cell. When the balance shifts towards more 
fusion, the mitochondria exhibit a larger and longer shape, whereas shifting towards the opposite 
direction results in smaller and more punctated mitochondria. An intriguing but still unsolved 
question arises as how mitochondrial morphology may affect the function of mitochondria. It has 
been suggested that mitochondrial shape may directly affect their bioenergetic activity. 
Elongated mitochondria are thought to have enhanced ATP production efficiency and can protect 
mitochondria from stressful conditions, whereas fragmented mitochondria are usually seen under 
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pathological conditions such as uncoupling and membrane depolarization. Not enough 
experimental results have proven the causal relationship between mitochondrial fragmentation 
and low energy production. A recently published study suggests that the short form of OPA1, 
which is usually linked with mitochondrial fragmentation, is more capable of ATP generation 
compared to the long form only (Lee et al., 2020a).  
Evidence from neurons suggests that certain cell types may be more sensitive for 
mitochondrial shape change than others. In neurons, mitochondria need to be transported out 
from the cell body, traveling along axons and reaching to the dendritic terminals. Smaller 
mitochondria are thought to be transported more efficiently than larger and longer mitochondria 
during this process. Overexpression of Drp1 lead to increased mitochondrial fission, and has 
been shown to increase dendritic mitochondria, associated with enhanced density of synapses (Li 
et al., 2004; Verstreken et al., 2005). The failure of elongated mitochondria to be transported into 
nerve terminals may result from entanglement of long mitochondria in the soma. Blocking 
fission process causes mitochondria elongation and interconnection, decreasing the efficiency of 
mitochondrial transport into axons, which can potentially be explained by mitochondrial 
entanglement in the cell body. Fusion process disruption does not increase the transport 
efficiency, although mitochondria can get fragmented under this condition. This can be explained 
by the direct physical interaction between fusion protein mitofusins and transport proteins 
including Miro and Milton (Misko et al., 2010). By disrupting the mitochondrial outer membrane 
fusion, the transport machinery is severed and cannot support axonal mitochondrial transport.  
 
Inter-mitochondria Content Exchange Facilitation 
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Mitochondrial fusion involves not only membrane mixing but more importantly matrix 
mixing and content exchange. The content exchange feature has extensive benefits to the cell, 
including maintaining a homogeneous mitochondrial population and tolerance of mtDNA 
mutations. Since mitochondria import most of the proteins from cytosols, the distribution and 
components of different proteins among various mitochondria within a cell may differ slightly 
due to spatial and temporal difference. Without fusion, the variations get more enhanced and 
eventually lead to inter-mitochondrial differences, which can lead to pathogenesis if a certain 
portion of mitochondria gets unhealthy. Similarly, fusion enables ameliorating pathological 
effects caused by excessively mutated and damaged mtDNA. Most mtDNA mutations causing 
mitochondrial disease are recessive, and need to reach a high percentage of 60-90% to be 
pathogenic. By fusing a mitochondrion with no or low level of mtDNA with a mitochondrion 
with relatively high level of mtDNA, the heteroplasmy level can be mitigated and therefore can 
avoid respiratory defects caused by high level mtDNA mutations (Chen et al., 2010).  
 
mtDNA Stability Maintenance 
 
Cells with no mitochondrial fusion contain extremely low levels of mtDNA. MEFs 
lacking both mitofusins or OPA1 alone retain only 1/3 of the mtDNA amount compared to that 
in WT cells (Chen et al., 2010). It is well established that mtDNA encodes 13 polypeptides that 
are part of the OXPHOS complexes, therefore, reduced levels of mtDNA lead to a huge 
reduction of OXPHOS activity. The OXPHOS deficiency is likely a combination of mtDNA loss 
and fusion defect, especially in OPA1 null cells, as OPA1 has been shown to be involved in 
cristae structure maintenance and respiratory complex stability. On the other hand, cells deficient 
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in mitochondrial fission also exhibit mtDNA defects. In fission deficient cells, mtDNA are not 
properly distributed, rather the mtDNA nucleoids aggregate and form large structures that 
deform mitochondrial tubules (Ban-Ishihara et al., 2013). The clustering of nucleoids results in 
uneven distribution of mtDNA within the mitochondria and causes mosaic OXPHOS deficits in 
cells (Ishihara et al., 2015). This dependence of the mtDNA level on fusion and fission activity is 
not only seen in cultured cells but also in various high energy demanding tissues such as mouse 
skeletal muscle (Chen et al., 2010) and cardiomyocytes (Ishihara et al., 2015).  
  
Cellular Stress Adaptation 
 
Previous studies have shown that mitochondrial fusion and fission activity can be 
modulated according to various cellar stresses. Certain stressors such as RNA transcription 
inhibitors, protein translation inhibitors, UV irradiation, and nutrient starvation inducers all cause 
super elongated mitochondria (Tondera et al., 2009a).  This phenomena is termed stress-induced-
mitochondrial-hyperfusion (SIMH). Fusion proteins MFN1 and OPA1 are necessary for this 
elevated fusion process in response to the first three stress inducers. Along with the hyperfusion 
process, cells showed increased ATP production to better survive under these stresses.  Fusion 
mutant cells show increased vulnerability to stress and more readily undergo apoptosis, possibly 
due to the inability of initiating the hyperfusion process. 
Other studies have indicated the role of mitochondrial fission in mitochondrial elongation 
under serum and amino acid starvation (Gomes et al., 2011; Rambold et al., 2011). In contrast to 
conditions discussed above, inhibition of fission instead of activation of fusion results in 
mitochondrial elongation. More specifically, Drp1 recruitment to mitochondria is disrupted when 
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cells are starved. The fission inhibition is thought to be a mechanism for mitochondria to escape 
autophagy/clearance under this particular stress condition. Cells that possess mutations inhibiting 
the elongation process show an elevated level of mitophagy under the starvation condition.  
Mitochondrial Quality Control 
The degradation of mitochondria is completed by mitophagy, where damaged 
mitochondria are degraded through a specialized autophagy machinery starting with engulfment 
by autophagosome followed by fusing with lysosome forming auto-lysosome and then later for 
final degradation in lysosome. During the first step of mitophagy, the damaged mitochondria 
need to be recognized and isolated from the healthy mitochondria, and this process is completed 
by the mitochondrial fusion and fission processes. To begin with, the dysfunctional 
mitochondria, which usually show inner membrane depolarization, can no longer fuse with the 
rest of the healthy population due to increased processing of Opa1 induced by the activation of 
Oma1 (Twig et al., 2008). Additionally, OXPHOS activity also regulates Opa1 cleavage and 
function, with increased fusion under highly oxidative conditions. Cells that do not have proper 
OXPHOS activity also cannot fuse due to Opa1 inactivity. On the other hand, fission can 
promote the segregation of damaged mitochondria as well as further divide targeted 
mitochondria into smaller pieces to facilitate the autophagosome engulfment process. In 
mammalian cells, inhibition of Drp1-mediated mitochondrial fission prevents Parkin-induced 
mitophagy, a well-known pathway regulating selective mitochondrial degradation. Finally, 
during Parkin-mediated mitophagy, unbiquitination of mitofusins and other mitochondrial outer 
membrane proteins are observed and lead to protein degradation (Tanaka et al., 2010). This 




Outline of thesis 
In my thesis, I will be discussing the novel finding of the inner membrane fusion protein 
OPA1 on its cleavage process and related physiological functions. One of the most important 
issues regarding the long and short forms of OPA1 remains unelucidated—how both forms 
coordinate together for mediating fusion, in particular, how important is short OPA1 in the 
fusion process, given the fact that half of the isoforms produce exclusively short forms. What 
conditions favor more balanced long and short forms, more proteolytic cleaved forms, whereas 
other conditions may prefer exclusively long forms. To better understand the role of s-OPA1, we 
used CRISPR-Cas9 gene editing to generate Opa1 cleavage site knockout cell lines and mouse 
models. In Chapter 2, I will talk about how a novel S3 cleavage site of Opa1 was discovered, the 
protease cleaving at the site, the exact cleavage site within the exon, and the physiological 
function of this novel cleavage site as well as how it is involved in mediating fusion activity. 
Lastly, in Chapter3, I will briefly discuss the implications of my findings, how it can help 
improve the current model together with other studies, and the future research needed to further 




Fig. 1.1 Mitochondria Cristae Structure (modified from Lee et al., 2020a). OM: outer 
membrane; IM: inner membrane; IBM: inner boundary membrane; IMS: inter membrane space; 
CJ: cristae junction; ICS: intra cristal space; ETC: electron transport chain. 
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Fig. 1.2 Human OPA1 isoforms overview. At least 8 Opa1 mRNA splice variants exist 
in human cells. Isoforms 1, 2, 4, and 7 generate both l- and s- OPA1, whereas isoforms 3, 5, 6, 
and 8 produce only s-OPA1 due to the presence of exon4b. MPP: mitochondrial processing 
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OPA1, a large GTPase of the dynamin superfamily, mediates fusion of the mitochondrial 
inner membranes, regulates cristae morphology, and maintains respiratory chain function. Inner-
membrane-anchored long forms of OPA1 (l-OPA1) are proteolytically processed by the OMA1 
or YME1L proteases, acting at cleavage sites S1 and S2, respectively, to produce short forms (s-
OPA1). In both mouse and human, half of the mRNA splice forms of Opa1 are constitutively 
processed to yield exclusively s-OPA1. However, the function of s-OPA1 in mitochondrial 
fusion has been debated, because in some stress conditions, s-OPA1 is dispensable for fusion. By 
constructing cells in which the Opa1 locus no longer produces transcripts with S2 cleavage sites, 
we generated a simplified system to identify the new YME1L-dependent site S3 that mediates 
constitutive and complete cleavage of OPA1. We show that mitochondrial morphology is highly 




By controlling mitochondrial form and function, the dynamics of mitochondrial fusion 
and fission regulate cellular physiology, including responses to metabolic demands and cellular 
stress (Chan, 2019). As double-membrane organelles, mitochondria fuse by a two-step process 
coordinated by a set of dynamin superfamily GTPases. In mammalian cells, mitochondrial outer 
membrane fusion mediated by the mitofusins MFN1 and MFN2 is followed by inner membrane 
fusion mediated by OPA1 (Chan, 2019). Each of these fusion molecules is essential for 
embryonic development in mouse (Chen et al., 2003b; Alavi et al., 2007). In humans, 
heterozygous mutations in MFN2 and OPA1 cause the neurodegenerative diseases Charcot-
Marie-Tooth Disease 2A and Autosomal Dominant Optic Atrophy, respectively (Alexander et 
al., 2000a; Delettre et al., 2000b; Chan, 2019). 
Due to alternative splicing and post-translational processing, the OPA1 locus gives rise to 
a complicated set of protein isoforms. In humans, OPA1 encodes for 8 mRNA splice forms that 
are generated by alternative splicing of exons 4, 4b, and 5b (Fig. S2.1A). The encoded OPA1 
polypeptides are directed into mitochondria due to an N-terminal mitochondrial targeting sequence 
(MTS) that is cleaved by the mitochondrial processing peptidase (MPP) soon after entry of this 
region into the matrix. Lateral exiting of the polypeptide from the TIM (translocase of the inner 
membrane) pore results in a “long” form of OPA1 (l-OPA1) that is anchored in the mitochondrial 
inner membrane by an N-terminal transmembrane segment. A fraction of l-OPA1 is proteolytically 
cleaved beyond the transmembrane segment by either OMA1 or YME1L, inner membrane-
anchored proteases, to produce slightly different, non-membrane-anchored, “short” forms (s-
OPA1). OMA1 cleaves at the S1 site encoded by exon 5 (Head et al., 2009; Ehses et al., 2009), 
and YME1L cleaves at the S2 site encoded by the alternative exon 5b (Song et al., 2007b; Griparic 
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et al., 2007b). For isoforms 1, 2, 4, and 7, the moderate action of these proteases typically results 
in roughly comparable levels of long versus short OPA1. In contrast, the polypeptides encoded by 
the other 4 mRNA splice forms (3, 5, 6, and 8), which all contain exon 4b, are such avid substrates 
for proteolytic processing that they generate only short forms (Song et al., 2007b; Griparic et al., 
2007b) (Fig. S2.1A). Although little detail is available, it has been suggested that exon 4b may 
encode a protease cleavage site (Head et al., 2009; Olichon et al., 2007; Lee et al., 2017b). Under 
normal conditions, a balanced combination of long and short forms is required to maintain high 
levels of  mitochondrial fusion (Song et al., 2007b). Proteolytic processing of the OPA1 ortholog 
Mgm1p is also necessary for normal levels of mitochondrial fusion in yeast cell (DeVay et al., 
2009). In contrast, either s-OPA1 or l-OPA1 is sufficient for the non-fusion functions of OPA1, 
such as maintenance of mtDNA, cristae structure, and respiratory chain assembly (Del Dotto et 
al., 2017; Lee et al., 2017). 
These observations raise several important issues. How do long and short forms of OPA1 
contribute to mitochondrial inner membrane fusion? In particular, what is the purpose of the short 
forms of OPA1, given that 4 of 8 mRNA splice isoforms give rise to exclusively short forms? 
There are currently two general models explaining how long and short OPA1 isoforms regulate 
inner membrane fusion activity. The first model is that a mixture of long and short forms is critical 
for fusion (Song et al., 2007; Mishra et al., 2014). This model is based on cell culture observations 
that expression of l-OPA1 or s-OPA1 alone results in very low mitochondrial fusion activity and 
that robust levels of fusion require a combination of both long and short forms (Song et al., 2007b). 
Furthermore, in an in vitro fusion assay, mitochondria containing l-OPA1 do not fuse until partial 
proteolytic cleavage is triggered (Mishra et al., 2014b). The second model is that l-OPA1 and s-
OPA have distinct activities, with l-OPA1 being the only fusogenic form. This model is based on 
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the observation that cells lacking OMA1 and YME1L, which produce only long forms of OPA1, 
nevertheless show tubular mitochondria and mitochondrial fusion activity (Anand et al., 2014b). 
In addition, under a stress condition termed stress-induced mitochondrial hyperfusion, l-OPA1 is 
sufficient for fusion activity (Tondera et al., 2009b). These observations indicate that under 
specific cellular conditions, l-OPA1 alone can have substantial fusion activity, even though this 
does not appear to be the case under basal conditions. S-OPA1 has instead been suggested to have 
fission activity, based on the observation that overexpression of s-OPA1 leads to mitochondrial 
fragmentation (Anand et al., 2014b). Recent reconstitution of OPA1 fusion activity in vitro (Ban 
et al., 2017b) has not distinguished between these two models, because both l-OPA1 and s-OPA1 
show liposome fusion activity (Ban et al., 2018a). However, consistent with the first model, s-
OPA1 seems to work synergistically with l-OPA1 to increase in vitro fusion activity (Ban et al., 
2017b). 
To understand the role of the short forms of OPA1, we used CRISPR-Cas9 gene editing to 
generate cells and mice lacking OPA1 isoforms containing the YME1L-dependent S2 site encoded 
by exon 5b. This genetic change eliminated all OPA1 isoforms containing this exon, and we 
anticipated that the role of YME1L in regulating OPA1 function would be abrogated due to the 
elimination of the YME1L cleavage site. Surprisingly, however, OPA1 processing was still 
regulated by YME1L due to a novel cleavage site, that we term S3, encoded by the alternative 
exon 4b. Notably, isoform 5 contains exon 4b and is constitutively cleaved at S3, and therefore 
this mRNA isoform contributes only s-OPA1 to the OPA1 repertoire. In specific cellular contexts, 
we show that depletion of S3-generated s-OPA1 causes mitochondrial fragmentation, and 
conversely, that increased expression of S3-generated s-OPA1 induces mitochondrial elongation. 
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OMA1 and YME1L differentially modulate OPA1 fusion activity 
Whereas human OPA1 has 8 different mRNA splice variants (Fig. S2.1A), mouse tissues 
express only four—isoforms 1, 5, 7, and 8 (Akepati et al., 2008) (Fig. 2.1A). Isoforms 1 and 7 each 
produce a mixture of l-OPA1 and one or two versions of s-OPA1, respectively. The short isoforms 
are produced by proteolytic cleavage of the long isoform by the mitochondrial inner membrane 
proteases OMA1 (at the S1 site) and YME1L (at the S2 site). In contrast, proteolytic processing 
of isoforms 5 and 8 goes to completion and results in only short isoforms (Song et al., 2007b). 
In mouse embryonic fibroblasts (MEFs), this group of 4 mRNA isoforms gives rise to five 
protein bands when cell lysates are resolved on SDS-PAGE (labeled a-e in Fig. 2.1A, B). Bands a 
and b are the long forms arising from isoform 7 and isoform 1, respectively (Fig. 2.1A). Bands c 
and d are S1- and S2-cleavage products of isoform 7 generated by OMA1 and YME1L, 
respectively. Band e is the short, S1-cleaved form of isoform 1. Isoforms 5 and 8 generate only 
short isoforms that would be expected to contribute to bands c-e (Song et al., 2007b). The same 
set of OPA1 bands has been observed in other studies, although the relative intensities can vary, 
perhaps due to differences in culture conditions (Anand et al., 2014b).  
The dependencies of bands c-e on the OMA1 or YME1L proteases were confirmed by the 
OPA1 band pattern in lysates from Oma1-null or Yme1l-null cells (Fig. 2.1B). The OPA1 band 
patterns observed in the protease mutant cells are tabulated in Fig. S2.1B. The identities of the 
Oma1-null and Yme1L-null cells were confirmed by Western blotting against the relevant 
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proteases (Fig. S2.1C). Notably, there is a longer band emerging in both the Yme1l-null and 
Yme1l/Oma1-null cells, likely due to the disruption of YME1L-dependent short isoform formation 
(i.e., isoform 8). 
To understand the role of these proteases in regulating OPA1 fusogenic function, we 
examined Oma1/Yme1l double knockout MEFs, which contain only long forms of OPA1 (Anand 
et al., 2014b). In standard high glucose culture medium, these cells show increased mitochondrial 
fragmentation compared to wildtype (WT) cells (Fig. 2.1C, D). Many Oma1/Yme1l mutant cells 
nevertheless show short tubular mitochondria (Fig. 2.1D), so the degree of mitochondrial 
fragmentation is substantially less severe than in Mfn1/Mfn2-null or Opa1-null cells (Chen et al., 
2005a, 2007). Oma1-null MEFs show normal mitochondrial morphology profiles, and Yme1l-null 
MEFs show highly fragmented mitochondria (Fig. 2.1D). The overall trends—that mitochondria 
in Oma1/Yme1l mutant cells are more fragmented than in WT cells, but less than in Yme1l mutant 
cells—are consistent with a previous study (Anand et al., 2014). OPA1 band patterns are similar 
under the different media conditions (Fig. S2.1D). 
We tested how these mutant cells respond to culture conditions that increase the level of 
mitochondrial fusion. Cultured MEFs increase mitochondrial fusion activity and show 
mitochondrial elongation when cultured in medium that induces oxidative phosphorylation 
(OXPHOS). This response has been shown to depend on YME1L activity (Mishra et al., 2014b). 
Consistent with this idea, we found mitochondrial elongation caused by OXPHOS-inducing 
medium to be abrogated in Yme1l-null and Oma1/Yme1l-null MEFs (Fig. 2.1C, D). As measured 
in the photo-activatable (PA)-GFP fusion assay, mitochondrial fusion under basal conditions was 
substantially reduced in Oma1/Yme1-null MEFs compared to WT cells and did not increase in 
response to OXPHOS-inducing medium (Fig. 2.1E). In contrast, cells of all genotypes tested in 
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this study show robust mitochondrial elongation in response to cycloheximide (CHX) treatment, 
which causes stress-induced mitochondrial hyperfusion (Tondera et al., 2009b)  (Fig. 2.1C, D, E). 
Hyperfusion is induced rapidly after the addition of CHX (Fig. 2.1E). CHX treatment enhanced 
PA-GFP signal dilution in both WT and Oma1/Yme1l-null cells. WT cells showed a substantially 
greater fusion rate than the latter, indicating the reduced fusion capability in Oma1/Yme1l-null 
cells even in the presence of a strong fusion stimulus. Taken together, our observations agree with 
the previous finding that Oma1/Yme1l-null cells, containing only l-OPA1, retain mitochondrial 
fusion activity (Anand et al., 2014b). However, the level of fusion activity is substantially lower 
compared to WT cells. The OMA1 and YME1L proteases differentially regulate OPA1 function. 
Stress-induced hyperfusion does not depend on either protease, consistent with the report that l-
OPA1 is sufficient in mediating fusion under this stress condition (Tondera et al., 2009b). In 
contrast, OXPHOS-induced mitochondrial elongation is dependent on YME1L activity, as noted 
previously (Mishra et al., 2014b).  
 
The Opa1 S2 site is necessary for mediating OXPHOS-induced fusion in vivo 
To clarify the functions of YME1L-dependent cleavage of OPA1, we used CRISPR-Cas9-
mediated gene targeting in MEFs to generate mutations in the Opa1 genomic locus at exon 5b, 
which encodes the S2 cleavage site (Fig. 2.2A, B). We hoped to generate deletions in exon 5b that 
would disrupt the Opa1 reading frame, resulting in a downstream premature stop codon that would 
prevent the formation of functional OPA1 isoforms containing S2. In this scenario, the mutant 
cells would be expected to have only long isoform 1 (band b) and the corresponding S1 cleavage 
product (band e). Bands a, c, and d would be missing, because those arise from exon 5b-containing 
transcripts (Fig. 2.2B). 
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After the transient expression of Cas9 and sgRNA against the exon 5b target in MEFs, we 
identified multiple colonies that lacked bands a, c, and d (Fig. 2.2C). To ensure against clone-
specific effects, we used three or more ∆exon 5b clones in all our experiments, and results from 
two different clones are shown in the figures. DNA sequencing showed that clone 1 has a 
homozygous two-nucleotide deletion, and clone 2 has two longer deletions that each cause 
frameshifting (Fig. 2.2A).  
The ∆exon 5b cells showed normal mitochondrial profiles when grown in a regular 
glucose-containing medium. In addition, they showed a normal stress-induced hyperfusion 
response, dramatically elongating mitochondria upon CHX stimulation (Fig. 2.2D and Fig. 
S2.2A). In OXPHOS-inducing medium, however, the mutant cells did not show any elongation of 
mitochondria compared to growth in control medium, indicating that S2-cleavage of Opa1 is 
required for OXPHOS-induced hyperfusion. Although OXPHOS-inducing medium does not 
promote mitochondrial elongation in ∆exon 5b cells, we did not detect physiological 
consequences. The OXPHOS-inducing medium caused upregulation of oxygen consumption in 
these cells (Fig. S2.2B), indicating that the increase in respiratory function is not dependent on 
mitochondrial elongation. Moreover, both WT cells and ∆exon 5b cells showed similar cell growth 
after switching to the OXPHOS-inducing medium (Fig. S2.2C). In addition to MEFs, we generated 
two ∆exon 5b mouse lines. Western analysis of mutant tissues showed abrogation of Opa1 exon 
5b-containing protein bands (Fig. S2.2D). Despite this biochemical change in OPA1 isoforms, the 
mutant mice showed no obvious physiological dysfunction and gained weight normally (Fig. 




Detection of a new OPA1 cleavage site in WT and ∆exon 5b cells 
In the course of this study, we switched to a higher resolution gel system to study these 
OPA1 protein isoforms. With this new system, what was previously designated as band d in WT 
cells could be resolved into doublet bands, which we designate as d and d’ (Fig. 2.3A). Upon 
reanalysis, we realized that ∆exon 5b cells produce two short Opa1 bands, d’ and e. With the 
deletion of the YME1L-dependent S2 site, ∆exon 5b cells would be expected to show only OMA1-
mediated processing of OPA1. In ∆exon 5b/Oma1-null cells, band e is missing, but d’ band 
remains, indicating that it is OMA1-independent (Fig. 2.3A). 
Because YME1L is the other known intermembrane protease involved in OPA1 
posttranslational processing, we used shRNA to test whether it is essential for the production of 
band d’. The knockdown efficiencies of the Yme1l and Oma1 shRNAs were confirmed by Western 
blotting (Fig. S2.3A, B). In WT cells, knockdown of YME1L caused the disappearance of band d 
and d’, whereas knockdown of OMA1 caused the disappearance of bands c and e (Fig. 2.3B). The 
dependence of d’ on YME1L but not OMA1 was further confirmed in both ∆exon 5b/Oma1-null 
cells and ∆exon 5b cells (Fig. 2.3B).  
To identify the source of the new short OPA1 band d’, we used PCR analysis of cDNA 
from ∆exon 5b cells to identify the major remaining Opa1 mRNA transcripts. Using primers 
flanking the alternative splicing exons 4, 4b, and 5b to distinguish individual mRNA transcripts 
(Fig. S2.3C), we found that the mutant cells expressed mRNA splice variants 1 and 5 (confirmed 
both by PCR analysis and sequencing), with isoform 1 being slightly more abundant (Fig. 2.3C, 
D). It is not surprising that isoforms 7 and 8 are missing, because they contain exon 5b. Isoform 5 
instead contains the alternative exon 4b (Fig 2.3D), and like other exon 4b-containing isoforms, 
was previously shown to be constitutively cleaved into a short isoform (Song et al., 2007b). The 
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constitutive cleavage of isoform 5 was assumed to occur at the S1 site, the only known cleavage 
site in this isoform (Song et al., 2007b). However, we wondered whether this assumption might be 
incorrect, because cleavage of isoform 5 at S1 would lead to band e, not d’. To test whether isoform 
5 could generate band d’, we expressed isoform 5 in Opa1-null cells. Isoform 5 generated a short 
isoform that was clearly distinct from e and co-migrated with the d’ bands present in ∆exon 5b and 
∆exon5b/Oma1-null cells (Fig. 2.3E). This observation indicates that isoform 5 is the likely source 
of band d’. Its cleavage site is N-terminal to S1, as indicated by the slightly larger size of d’ 
compared to e. 
To determine the protease responsible for cleavage of isoform 5, and further confirm that 
the YME1L-dependent band d’ indeed arises from isoform 5, we compared the behavior of C-
terminal FLAG-tagged human isoforms 5 and 1 in mutant MEFs lacking OMA1 or YME1L. 
Consistent with previous studies showing cleavage at S1 by OMA1, isoform 1-FLAG produces a 
short isoform that is dependent on OMA1 (Fig. 2.3F). When YME1L is absent, more of this short 
isoform is produced, presumably due to upregulation of OMA1 activity (Wai et al., 2015). As 
expected, isoform 5-FLAG is completely processed in control MEFs. The absence of OMA1 does 
not affect the cleavage pattern, indicating that the production of isoform 5 short form is 
independent of OMA1 (Fig. 2.3F). The removal of Yme1l completely abrogates production of this 
short form and results in a lower band that co-migrates with the short isoform generated from 
isoform 1 (Fig. 2.3F), as well as a small amount of long form. These results indicate that, under 
normal conditions, isoform 5 is processed exclusively at a site upstream of S1, in a YME1L-
dependent manner, to produce band d’. When YME1L is absent, cleavage is activated at the 
downstream S1 site. Isoform 5 produces only long form when both OMA1 and YME1L are absent 
(Fig. 2.3F, last lane). Together, the results suggest that OPA1 isoform 5 is highly susceptible to 
 47 
protease processing, normally by YME1L. OMA1 is also capable of processing isoform 5 into S1-
cleaved OPA1 in the absence of YME1L. No additional proteases are sufficient for isoform 5 
cleavage, as indicated by the formation of long isoform 5 when both Yme1l and Oma1 are absent.  
 
Identification of a leucine-rich, YME1L-dependent cleavage site in exon 4b 
Our results so far suggest that isoform 5 contains a novel YME1L-dependent cleavage site 
upstream of S1. To pinpoint the new cleavage site (which we designate as S3), we asked if cleavage 
is dependent on exon 4b, the first exon upstream of exon 5. Knockdown of exon 4b with shRNA 
substantially reduced the intensity of band d’ in WT, ∆exon 5b, and ∆exon 5b/Oma1-null cells 
(Fig. 2.4A, band d’ marked with asterisks). This dependence suggests that the cleavage site likely 
resides in exon 4b. To test this idea, we analyzed the behavior of a series of isoform 5 mutants 
(Mut 1-9) containing various short deletions within exon 4b (Fig. 2.4B). Mutants 1, 2, and 3, 
containing deletions in the 5’ half of exon 4b, show no defect in isoform 5 cleavage processing, 
indicating that the first half of exon 4b does not contain the cleavage site (Fig. 2.4C). Mutations 4, 
5, and 6 result in small amounts of the long form, which normally is absent. In addition, these 
mutants show prominent production of band e. Mutants 7 and 8 also show presence of the long 
form and band e. In addition, these mutants show novel cleavage products forming a smear above 
band e (Fig. 2.4C). Mutation 9, which deleted the bridging amino acids between exon 4b and 5, 
generates band e and produces new cleavage products without generating a long form of isoform 
5. These results suggest that S3 cleavage is sensitive to mutations in the 3’ half of exon 4b, and 
particularly to mutations (mutants 7 and 8) affecting a stretch of 5 consecutive leucines (amino 
acids 199-203 in isoform 5). Interestingly, the most prominent effects of the mutations are in 
appearance of the long form and novel cleavage products, rather than in elimination of band d’.  
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To determine the proteases responsible for cleavage of the mutants, we expressed the 
FLAG-tagged mutants in protease mutant MEFs (Fig. 2.4D). In mutants 6 and 7, the smallest 
cleavage product disappeared in Oma1-null cells, indicating that it is OMA1-dependent. In mutant 
7, there are larger short forms that are YME1-dependent.  In the absence of both OMA1 and 
YME1L, no cleavage was observed, demonstrating that these two proteases are essential for 
isoform 5 processing.   
To identify the cleavage site more precisely, we used tandem mass spectrometry to 
determine the N-terminal sequence of band d’, produced by overexpression of FLAG-tagged 
human isoform 5 in 293T cells. Band d’ was collected by immunoprecipitation against FLAG tag, 
resolved on SDS-PAGE, and isolated for biochemical analysis. Peptides were generated by trypsin 
digestion and identified by liquid chromatography coupled with nanospray ionization tandem mass 
spectrometry (LC-MS). Of the peptides identified, only three peptides had non-tryptic N-termini.  
The two predominant ones had N-termini located within exon 4b, beginning with the 
second to last leucine and last leucine of the penta-leucine stretch (Fig 2.4E). The latter peptide 
had by far the highest intensity, suggesting that it represents the predominant S3 cleavage product. 
To test this idea, we designed isoform 5 mutants (mutants 10-13) in which the last 1-3 leucines of 
the penta-leucine stretch were substituted with alanine. We found that substitution of a single 
leucine (mutants 12 and 13) had little effect on band d’ production, though a small level of larger 
cleavage products could be observed (Fig. 2.4F). When both of the last two leucines were 
substituted (mutant 11), there was a more substantial level of aberrant cleavage, and the long 
isoform appeared. Both these effects were increased when the last three leucines were substituted 
(mutant 10). Taken together, the LC-MS and mutational analysis strongly argue that the S3 
cleavage site lies within the penta-leucine stretch encoded by the end of exon 4b. Although the 
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product ion spectra indicated that cleavage primarily occurs N-terminal to the last leucine, the 
mutational phenotypes suggest that cleavage can occur at other locations very near the penta-
leucine stretch (Fig. 2.4C, lane 9-13). None of the mutations completely eliminate production of 
band d’, suggesting that cleavage can still occur very close to S3 when the site is mutated. It is also 
apparent that isoform 5 is highly prone to proteolytic processing—when the S3 site is mutated, 
cleavage is activated at S1 or at cryptic sites N-terminal to S3, leading to variant cleaved forms of 
isoform 5. Our analysis indicates that ∆exon5b cells retain two dominant Opa1 mRNA transcripts, 
isoforms 1 and 5.  This simplified transcript profile results in one l-OPA1 (from isoform 1) and 
two s-OPA1 (isoform 1/S1 and isoform 5/S3) (Fig. 2.4G). 
 
The S3-cleaved short form of isoform 5 regulates mitochondrial tubulation 
In both humans and mice, half of the Opa1 splice forms contain exon 4b and are 
constitutively cleaved to yield exclusively short isoforms (Song et al., 2007b). This raises the issue 
of why Opa1 encodes multiple mRNA splice forms whose only apparent purpose is to generate 
short isoforms. We used isoform 5 to address this issue. Consistent with previous studies (Song et 
al., 2007b), isoform 5 has almost no mitochondrial elongation activity when expressed in Opa1-
null MEFs, which have highly fragmented mitochondria due to the complete loss of inner 
membrane fusion (Fig. 2.5A, S5A, and S4A). Isoform 5 mutations that disrupt S3 processing, 
however, show substantial mitochondrial fusion activity, as indicated by their ability to elongate 
mitochondria (Fig. 2.5A, S5A and S4A, B). Because these mutants produce a variety of short forms 
as well as a long form, these results fit with the model that a mixture of long and short isoforms of 
OPA1 is important for mitochondrial fusion activity (Song et al., 2007b). Alternatively, these 
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results could be explained by proposing that it is the production of the long isoform that induces 
mitochondrial fusion activity. 
To distinguish between these two models, we further probed the physiological function of 
the short form of isoform 5. We used shRNA to knock down exon 4b in ∆exon 5b and ∆exon 
5b/Oma1-null cells, which have a simplified portfolio of Opa1 mRNA splice forms. As expected, 
knockdown of exon 4b resulted in reduction of band d’ in both cell lines (Fig. 2.4A, Fig 2.5B). In 
the ∆exon 5b MEFs, exon 4b knockdown leads to dramatic mitochondrial fragmentation (Fig. 
2.5C, Fig. S2.5B). Similarly, in ∆exon 5b/Oma1-null cells, knockdown of exon 4b results in 
mitochondrial fragmentation (Fig. 2.5C, Fig. S2.5B). To verify that the knockdown result is not 
due to off-target effects, we re-expressed isoform 5 in the exon 4b knockdowns (Fig. 2.5B) and 
observed elongation of mitochondrial morphology in both cell lines (Fig. 2.5C, Fig. S2.5B). 
To further test this idea that a short form of OPA1 can collaborate with a long form to 
regulate mitochondrial fusion, we developed an expression system to co-express two different 
OPA1 splice forms in Opa1-null MEFs. We constructed a bicistronic expression vector to generate 
isoform 1 along with isoform 5 or isoform 1 along with control YFP.  Western blot confirmed the 
expected OPA1 band pattern in these cells (Fig. 2.5D). With isoform 1 expression alone, the long 
band b and the short band e were produced. With bicistronic expression of isoform 1 and isoform 
5, an additional short form (d’ from isoform 5) was added. This dual expression recapitulated the 
bands observed in ∆exon 5b cells (Fig. 2.5D) and resulted in longer mitochondrial profiles. 
Significantly more cells contained interconnected mitochondria, and fewer cells had fragmented 
mitochondria, compared to expression of isoform 1 alone (Fig. 2.5E, Fig. S2.5C). These results 
suggest that S3-cleaved s-OPA1 can work with l-OPA1 to promote mitochondrial fusion. To 
determine whether this synergy requires GTP hydrolysis activity in s-OPA1, we used the 
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bicistronic system to express wildtype isoform 1 with isoform 5 containing a dysfunctional GTPase 
domain (iso 5-G300E) in Opa1-null MEFs. The protein band pattern was similar in cells expressing 
Iso 1-IRES-Iso 5-G300E compared to cells expressing Iso 1-IRES-Iso 5 (Fig. S2.5D). The mutated 
isoform 5 was ineffective at promoting mitochondrial fusion in combination with wildtype isoform 





The OPA1 locus has several mechanisms that safeguard the production of s-OPA1. Of the 
8 OPA1 mRNA isoforms in humans, 4 contain exon 4b (Delettre et al., 2001) and encode 
polypeptides that are fully processed to s-OPA1 (Song et al., 2007b). It remains to be determined 
why inclusion of exon 4b causes such extensive processing by YME1L. A short hydrophobic 
sequence (FAWFP) has been found to act as a degron for YME1L (Shi et al., 2016a). However, 
no similar sequences are apparent in exon 4b or the rest of OPA1. In the mouse, only 4 mRNA 
isoforms are expressed (Akepati et al., 2008), but  similar to humans, half of them contain exon 4b 
and produce only s-OPA1. Moreover, with our identification of S3, there are now three cleavage 
sites that result in the production of s-OPA1 (Fig. 2.5F). This apparent redundancy of sites ensures 
production of s-OPA1 when one mechanism is disrupted. There is evidence that s-OPA1 is 
important for cell health, especially under conditions of oxidative stress (Lee et al., 2020b). 
The redundancy of two YME1L-dependent sites (S2 and S3) likely explains why mice 
lacking the S2 site do not show obvious physiological abnormalities. In ∆exon 5b mice and cells, 
RNA isoforms retaining the S3 site are still present and produce sufficient levels of YME1-
dependent s-OPA1 to maintain cellular function. In addition to redundancy of S2 and S3, there 
appears to be crosstalk between sites to ensure cleavage of OPA1 precursors. With isoform 5, for 
example, mutation of the S3 site does not abrogate proteolytic processing of OPA1. Rather, it 
activates OMA1-dependent cleavage at S1 and YME1L-dependent cleavage at upstream cryptic 
sites, resulting in new short isoforms (Fig. 2.5F). Similarly, mutation of the S1 site activates cryptic 
cleavage sites (Song et al., 2007b). The presence of these multiple mechanisms to generate s-OPA1 
suggests that the processed forms likely play an important functional role. It is known that s-OPA1 
alone is functional for maintenance of mitochondrial DNA, respiratory complexes, and cristae 
 53 
structure (Lee et al., 2017c; Del Dotto et al., 2017a), but its role in modulating mitochondrial fusion 
has been less clear. 
Our results support a model in which s-OPA1 collaborates with l-OPA1 to regulate 
mitochondrial inner membrane fusion. This principle can be readily observed in our engineered 
cells that have various altered combinations of OPA1 isoforms. In ∆exon 5b/Oma1-null cells, only 
one long form and one short form are produced. Further reduction of s-OPA1 in these cells causes 
dramatic mitochondrial fragmentation (Fig. 2.5C). Although the long forms by themselves can 
have fusion activity under certain contexts (mainly the stress-induced hyperfusion condition) 
(Tondera et al., 2009b), l-OPA1 alone is ineffective at maintaining tubular mitochondrial 
morphology after exon 4b is knocked down in exon 5b/Oma1-null cells, which then produce only 
the long form of isoform 1 (band b). Similarly, cells expressing both isoform 1 and 5 show more 
tubular mitochondria compared to cells expressing only isoform 1, suggesting that additional 
production of s-OPA1 in this case promotes mitochondrial fusion (Fig. 2.5E). These results suggest 
that the ratio of l-OPA1 to s-OPA1 is an important parameter affecting fusion levels.  
At present, there is no evidence that the various short forms of OPA1 are functionally 
distinct with respect to their role in mitochondrial fusion. Our working model is that all the short 
forms are functionally similar. Mechanistically, the enhancement of tubular mitochondria by s-
OPA1 requires its GTP hydrolysis activity (Fig. S2.5C, E), suggesting that it plays an enzymatic 
role in this process. The multiple cleavage sites allow for production of short forms under basal 
and stress conditions. 
Similar to these results, in an in vitro liposome fusion assay, l-OPA1 was sufficient to 
mediate membrane fusion, but the addition of increasing amounts of s-OPA1 to the same reaction 
caused higher levels of liposome fusion (Ban et al., 2017b). A previous study suggested that 
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overexpression of s-OPA1 leads to mitochondrial fission, a result interpreted as supporting a role 
in fission (Anand et al., 2014b). We cannot rule out a role of s-OPA1 in fission. However, it is 
possible that overexpression of s-OPA1 causes an imbalance of the l- to s-OPA1 ratio, which we 
have shown is critical for controlling mitochondrial dynamics. 
It should be noted that the S3 cleavage site we have discovered is a mechanism for constitutive 
cleavage in OPA1 isoforms containing exon 4b, rather than for induced cleavage under special 
physiological cues or cellular stress conditions, as is the case for S1 (constitutive and CCCP-
inducible). Unlike isoforms containing S1 and S2, which are partially cleaved to generate a 
cohort of long and short forms, isoforms containing S3 are fully processed under basal 
conditions to produce solely s-OPA1. The physiological importance of this constitutive cleavage 
is indicated by our results showing that removal of S3-containing isoforms can cause 
mitochondrial fragmentation under basal growth conditions. 
 
Materials and Methods 
 
Antibodies 
The following antibodies were used: anti-Actin (Mab1501R, Millipore), anti-HSP60 (SC-
1054, Santa Cruz Biotech), anti-FLAG (F-1804, Sigma), anti-OPA1 (612606, BD Biosciences), 
anti-TOMM20 (FL-145, Santa Cruz Biotech), anti-TUBULIN (T6199, Sigma), anti-OMA1 (sc-






Homemade 8% SDS-PAGE gel was used prior to switching to the high resolution gel 
system.  
High resolution gel system: The Bio-Rad Mini-PROTEAN precast gel system was used for 
Western blotting. 10ug of each cell lysate sample was loaded onto 7.5% Mini-PROTEAN TGX 
precast gels, run at 150 V at 4°C for 2 hours to resolve OPA1 bands, then transferred onto 
nitrocellulose membranes using Semi-dry Transfer Cell (Bio-Rad), immunoblotted with primary 
antibodies followed by horseradish peroxidase-conjugated secondary antibodies. Densitometry of 
Western blots was done using ImageJ. 
 
Plasmid construction and retroviral transduction 
The eight isoforms of human OPA1 cDNA were described previously (Song et al., 2007b). 
FLAG-tagged OPA1 isoforms were constructed by inserting a 3XFLAG sequence (amino acid 
sequence: DYKDHDGDYKDHDIDYKDDDDK) into the 3’ end of the OPA1 gene at the 
MfeI/NotI site. OPA1 sequences are highly similar between mouse and human (Fig. S2.4B). 
To generate the OPA1 bicistronic expression system, isoform 1 was cloned into pMSCV-
IRES-YFP II (Addgene, #52108) at BamHI/ApaI sites. Isoform 5 was then cloned into NcoI/HpaI 
sites, replacing YFP.  
To generate mutants of OPA1 isoform 5, primers containing deletion mutations were used 
to amplify 5’ and 3’ OPA1 fragments, which were then fused together by PCR. The amplified 
DNA fragments were subcloned back into the pMSCV-Opa1 isoform 5 vector and expressed via 
retroviral infection.  
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To disrupt Opa1 exon 5b, CRISPR-Cas9 sgRNA was analyzed by the online gRNA design 
platform at crispr.mit.edu. The gRNA sequence with the highest score was selected and cloned 
into the pSpCas9n(BB)-2A-Puro plasmid. Transfection and selection were done as previously 
reported (Ran et al., 2013). The guide RNA was generated by the following oligonucleotides:  
Forward:        CACCGGGGCATAGCTCGTGCTATAC 
Reverse:   AAACGTATAGCACGAGCTATGCCCC 
shRNAs were cloned into the BglII/EcoRI sites of the retroviral vector pRetroX-H1, which 
contains the H1 promoter. The shRNA target sequences were: 




All constructs were authenticated by DNA sequencing. 
 
Mouse breeding 
Cas9 mRNA and sgRNA targeting Opa1 exon 5b were injected into fertilized oocytes at 
the one cell stage by the Transgenic/Knockout Rodent Core Facility at USC. The genotypes of the 
animals were analyzed by PCR and DNA sequencing, and animals with frameshift mutations were 
selected. Two homozygous mutant mouse lines—one with a 13-nucleotide deletion and the other 
with a 44-nt deletion—were found to lack OPA1 transcripts containing exon 5b. These ∆exon 5b 
mice were subsequently crossed to Oma1-null mice to generate ∆exon 5b/Oma1-null animals. 
Mouse experiments were conducted under protocols approved by the Caltech Institutional Animal 
Care and Use Committee.  
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Cell lines and cell culture 
MEFs (mouse embryonic fibroblasts) were maintained in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin at 37 °C and 5% CO2. The OXPHOS-inducing medium and glycolytic 
medium were described previously (Mishra et al., 2014b).  
The Opa1-null, Oma1-null, Yme1l-null, and Oma1/Yme1l-null MEFs were described 
previously (Song et al., 2007b; Anand et al., 2014b). To generate ∆exon 5b MEFs, WT MEFs were 
transiently transfected with the CRISPR-Cas9 plasmid. 24 hours later the transfected MEFs were 
selected with 1 µM puromycin for 24 hours, and cells were cloned by limiting dilution in 96-well 
plates. After expansion, the clones were lysed with RIPA buffer (ThermoFisher Scientific) and 
analyzed by Western blotting against OPA1. Clones with the expected OPA1 band pattern were 
expanded, and their genotypes were confirmed by DNA sequencing.  
To generate ∆exon 5b/Oma1-null fibroblasts, cells were isolated from ∆exon 5b/Oma1 
mouse tails at postnatal day 21 and grown in DMEM supplemented with 10% fetal bovine serum 
(FBS), essential amino acids, and penicillin/streptomycin at 37 °C and 5% CO2. The fibroblasts 
were immortalized by expression of SV40 large T antigen. The genotype of the cells was 
confirmed by PCR and immunoblotting.  
 
Cell respiration measurement 
Oxygen consumption rate was measured in a Seahorse Biosciences Extracellular Flux 
Analyzer (model XF96), as described previously (Mishra et al., 2014b). 
 
 58 
Imaging and quantification 
All images were acquired with a Zeiss LSM 710 confocal microscope with a Plan-
Apochromat 63X/1.4 oil objective. Alexa 488 and Alexa 546 conjugated dyes were excited by the 
488 nm laser and the 561 nm laser, respectively. Mitochondria were visualized and imaged by 
immunostaining with Tom20 antibody. 
To determine mitochondrial fusion activity, cells were visually scored under a fluorescent 
microscope (Axiovert 200M; Carl Zeiss MicroImaging, Inc.) into four morphological 
classifications. Scoring was done manually, blinded. “Fragmented” refers to cells that contain 
spherical mitochondrial fragments with no more than two short tubules found. “Short tubular” 
refers to cells with a mixture of fragmented and short tubular mitochondria. “Long tubular” 
refers to cells in which mitochondria were elongated, but not highly interconnected into a 
mitochondrial mesh. “Interconnected” refers to cells in which mitochondria formed a highly 
interconnected network of mitochondrial filaments, with few isolated mitochondria. All data are 
presented as mean ± s.d (standard deviation) unless otherwise noted. Quantitative data were 
analyzed by Student’s t-test for the comparison between two groups (two tailed, unpaired). 
 
 
PA-GFP fusion assay 
Cells expressing matrix DsRed and photoactivatable GFP (PA-GFP) targeted to either the 
OM or matrix were plated on glass coverslips and imaged live at 37°C on an LSM 710 confocal 
microscope (Carl Zeiss, Inc.). Measurements were initiated 1-2 hours after medium change. PA-
GFP was photoactivated in a region of interest (5 μm × 5 μm) by illumination with a 405 nm laser. 
The activated fluorescent signal was then collected (for the entire cell) every 3 min for the next 
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30 min using a spectral detector, followed by spectral unmixing based on the individual PA-GFP 
and DsRed spectra. Fusion events result in the dilution of the activated signal. The average pixel 
intensity (for the entire cell) over time is a measurement of fusion rates (Karbowski et al., 2014). 
Images were analyzed in MatLab (Mathworks, Inc.). P values were calculated using a Student’s t 
test on the slopes of intensity versus time for individual measurements (>20 per condition). 
 
Mass Spectrometry 
At 48 hours after transient transfection of FLAG-tagged isoform 5 in 293T cells, cell 
lysates were harvested and immune-precipitated against FLAG. Concentrated samples were run 
on SDS-PAGE, and colloidal Coomassie blue stain (Invitrogen) was used to identify the bands. 
The desired bands were excised, finely diced, and transferred to a microcentrifuge tube. The gel 
pieces were reduced, alkylated, and digested by trypsin overnight at 37° C. Digested peptides were 
extracted from the gel, lyophilized, and desalted by C18 ZipTips (EMD Millipore). The peptides 
were separated with a 60 min gradient at a flow rate of 220 nL/min using a nanoflow LC system, 
EASY-nLC 1000, (Thermo Fisher Scientific). The separated peptides were ionized by a Nanospray 
Flex ion source and subjected to MS/MS analysis using a Fusion Orbitrap mass spectrometer 
(Thermo Fisher Scientific, San Jose). LC-MS/MS Data Analysis: The Thermo raw data file was 
converted to mzML file using MSconvert. The mzML file was searched using MS-GF+ against 
the Opa1 sequence. Default options were used except precursor mass tolerance was set to 7 ppm, 
instrument was specified to “Orbitrap/FTICR/Lumos” (1), and the enzyme was “Unspecific 
cleavage” (0). Results were further refined by filtering out all peptide-spectrum matches with an 
E-value greater than 0.001.
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Figure 2.1: OMA1 and YME1L differentially regulate OPA1 fusion activity. 
(A) Schematic of mouse OPA1 protein isoforms, showing the origin of protein bands a-e. MEFs 
express isoforms 1, 5, 7, and 8. Isoforms 1 and 7 produce long forms that constitute bands a-b and 
short forms that constitute bands c-e. Isoforms 5  and 8 produce exclusively short forms expected 
to co-migrate with bands c-e, but for simplicity, bands c-e are labeled according to their origin 
from isoforms 1 and 7. The MPP (Mitochondrial Processing Peptidase), S1 (by OMA1), and S2 
(by YME1L) cleavage sites are indicated with arrows. Orange line and arrows show that band c 
and d are derived from long isoform 7/a, pink line and arrow show that band e is derived from the 
long isoform 1/b. (B) Western blot analysis of OPA1 bands in Oma1 and Yme1l mutant MEFs. 
Five OPA1 bands (a-e) are apparent in wildtype MEFs. Oma1-null MEFs lack c and e; Yme1l-
null MEFs lack d; and Oma1/Yme1l-null MEFs lack all the short forms, c-e. Tubulin was used as 
loading control. (C) Representative images of mitochondrial morphology (mito-DsRed) in WT 
and protease-null MEFs in different media. GLY: high glucose medium; OXI: OXPHOS-inducing 
medium; CHX: high glucose medium with 10 M cycloheximide. Insets show magnified view. 
Scale bar, 5 µm. (D) Quantification of mitochondrial morphology of cells in (C). In each 
experiment, 100 cells were scored. Error bars show standard deviation from three independent 
experiments. (E) Comparison of mitochondrial fusion rates in vivo in different media between WT 
and Oma1/Yme1l-null MEFs. Fusion activity was measured by the intensity reduction of PA-GFP 




Figure 2.2: The S2 site encoded by Opa1 exon 5b is necessary for OXPHOS-induced fusion 
in vivo. 
(A) Schematic of exon 5b, showing locations of S2 and CRISPR-Cas9 gRNA target. Deletions 
present in clones 1 and 2 are indicated. (B) Schematic of OPA1 isoform composition after exon 
5b-containing isoforms are eliminated; Red X’s indicate isoforms expected to be missing in mutant 
cells. (C) Western blot analysis of ∆exon 5b MEF clones. Clones 1 and 2 are positive clones that 
show the expected disappearance of bands a, c, and d. The last lane is a negative clone. Tubulin 
was used as loading control. (D) Quantification of mitochondrial morphology in WT and two 
∆exon 5b clones in the indicated media. 100 cells were counted for each experiment. Error bars 
indicate standard deviation from three independent experiments. 
 
Figure 2.3: Detection of a new OPA1 cleavage in WT and ∆exon 5b cells. 
(A) Higher resolution Western analysis of WT, ∆exon 5b, and ∆exon 5b/Oma1-null MEFs. Note 
the additional band located under d in WT MEFs. This band (referred to as d’) is more clearly seen 
in ∆exon 5b and ∆exon 5b/Oma1-null clones. HSP60 was used as loading control. (B) Dependence 
of band d’ on Yme1l. Cells expressing the indicated shRNA were analyzed by Western blotting. 
The two sets of panels were run on the same gel. HSP60 was used as loading control. (C) PCR 
analysis of Opa1 transcripts in ∆exon 5b cells. The forward primer is located in exon 3, and the 
reverse primer is located in exon 7 (Fig. S3C). Bands corresponding to isoforms 1 and 5 were 
confirmed by sequencing. (D) Schematic of full-length OPA1 isoforms 1 and 5. (E) Western blot 
analysis of the short form produced by isoform 5; HSP60 was used as loading control. (F) 
Dependence of isoform 5 band d’ on YME1L. FLAG-tagged human OPA1 (isoform 1 or 5) was 
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expressed in cells of the indicated genotype and analyzed by Western blotting against FLAG; 
HSP60 was used as loading control. 
 
Figure 2.4: Identification of the YME1L-dependent OPA1 S3 cleavage site within exon 4b. 
(A) Dependence of band d’ on exon 4b. ShRNA against Opa1 exon 4b was expressed in cells of 
the indicated genotype. Asterisks highlight band d’. HSP60 was used as loading control. (B) 
Schematic of Opa1 exon 4b mutants. On top, the polypeptide sequence encoded by exon 4b (red) 
and exon 5 (blue) is shown. The red arrow indicates the known S1 cleavage site in exon 5; the 
green arrows indicate the new S3 sites found in this study. The isoform 5 mutants are listed, along 
with amino acids deleted within exon 4b. (C) Effect of exon 4b mutants on OPA1 processing. 
FLAG-tagged exon 4b mutants of human isoform 5 were expressed in Opa1-null MEF cells and 
analyzed by Western blot. FLAG-tagged WT isoforms 1 and 5 were used as controls. HSP60 was 
used as loading control. (D) Effect of OMA1 and YME1L on OPA1 processing in isoform 5 
mutants. WT human Iso 5 and its mutants 2, 6 and 7 were expressed in Oma1- and Yme1l- null 
MEFs; FLAG-tagged OPA1 band patterns were analyzed by Western blot. HSP60 was used as 
loading control. (E) Identification of likely S3 cleavage sites within exon 4b by tandem mass 
spectrometry of band d’. Band d’ was produced by expression of FLAG-tagged Opa1 isoform 5 in 
293T cells, purified by anti-FLAG immunoprecipitation, resolved by SDS-PAGE, digested by 
trypsin, and subjected to tandem mass spectrometry. Left: Schematic indicates the three ragged N-
terminal peptides identified, colored according to their relative intensity. Right: Plot of the 
intensity of the three peptides. (F) Effect of penta-leucine mutants on generation of band d’. As 
indicated, alanines were used to replace 1, 2, or 3 leucines within the C-terminal penta-leucine 
stretch encoded by exon 4b. FLAG-tagged mutants of isoform 5 were expressed in Opa1-null cells 
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and analyzed by Western blot. HSP60 was used as loading control. (G) Schematic of the OPA1 
isoform profile in ∆exon 5b MEFs. Green arrow represents the new S3 site identified.  
 
Figure 2.5: The S3-cleaved short form of isoform 5 regulates mitochondrial morphology. 
(A) Elongation of mitochondria by isoform 5 mutants. Isoform 5 mutants were expressed in Opa1-
null cells, and mitochondrial morphologies were quantified. Error bars indicate standard deviation 
from six independent experiments. (B) Depletion of band d’ by shRNA against exon 4b and re-
expression of d’ by isoform 5. Ectopic expression of isoform 5 is sufficient to overcome the shRNA 
effect and produce d’. OPA1 isoforms were analyzed by Western blotting against OPA1; HSP 60 
was used as loading control. (C) Effect of exon 4b shRNA on mitochondrial morphology. Error 
bars indicate standard deviation from three independent experiments. (D) Analysis of bicistronic 
OPA1 expression. Opa1-null cells expressing isoform 1 or isoform 1 plus isoform 5 were analyzed 
by Western blotting against OPA1. ∆exon 5b cells are shown for comparison. HSP60 was used as 
loading control. (E) Effect of band d’ on mitochondrial morphology. Quantification of 
mitochondrial morphology of Opa1-null MEFs expressing isoform 1 with YFP or isoform 1 with 
isoform 5. Error bars indicate standard deviation from three independent experiments. P values for 
the fragmented, short tubular, long tubular, and interconnected were 4.8x10-4, 0.04, 0.001, 9.9x10-
7, respectively. P-values were calculated by Student’s t-test. (F) Model showing the OPA1 
isoforms under normal and S3 disrupted conditions. When S3 is disrupted (bottom panel, box), 
cleavages at S1 and cryptic sites are activated, preserving production of s-OPA1. OM: outer 






















Figure 2.5: The S3-cleaved short form of isoform 5 regulates mitochondrial morphology. 
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Figure S2.1: OPA1 mRNA isoforms and the role of Oma1. 
(A) Schematic of the eight human OPA1 isoforms. The isoforms differ based on alternative 
splicing of exons 4, 4b, and 5b, and are grouped based on the production of l-OPA1 or s-OPA1. 
The sites of the S1 and S2 cleavage sites are indicated. MPP: mitochondrial processing 
peptidase. (B) Tabulation of the isoforms, band pattern and mitochondrial morphology in 
wildtype and protease mutant MEF lines. (C) Verification of protease mutant cell lines by 
Western blotting. OMA1 and YME1L Western blots show the absence of corresponding protease 
in each cell line. Tubulin was used as loading control. (D) OPA1 band pattern in protease mutant 
cells grown in different media conditions. GLY: high glucose medium; OXI: OXPHOS-inducing 
medium; CHX: high glucose medium with 10 M cycloheximide. 
 
Figure S2.2: Phenotypic characterization of ∆exon 5b MEFs and mice. 
(A) Representative images of mitochondrial morphology (Tom20 immunostaining) in WT and 
two ∆exon 5b MEF clones in different media (supplemental data for Fig. 2D). GLY: high 
glucose medium; OXI: OXPHOS-inducing medium; CHX: high glucose medium with 10 M 
cycloheximide. Scale bar, 5 m. (B) Seahorse data on cell respiration rate change after media 
switch from control glycolytic medium to OXPHOS-inducing medium. The blue arrow 
represents the time of media change. (C) Cell numbers in control glycolytic medium versus 
OXPHOS-inducing medium. Two sets of cells were seeded and grown in high glucose DMEM 
medium for 24 hours, washed with PBS, and transferred to control glycolytic medium or 
OXPHOS-inducing medium. Error bar: Standard deviation of three counts from the same 
experiment. (D) Western blot analysis of OPA1 in tissue lysates from WT and two ∆exon 5b 
mutant mice. The disappearance of band c was the most obvious change. Mut 1: mutant mouse 
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line with 13 nucleotides deletion in Opa1 exon 5b; Mut 2: mutant mouse line with 44 nucleotides 
deletion in Opa1 exon 5b. (E) Weight of ∆exon 5b (Mut 2) animals at week 24. Error bars 
indicate standard deviation; n=6 for each group. 
 
Figure S2.3: shRNA knockdown efficiency and primer design for Opa1 mRNA 
identification. 
(A) Efficiency of Oma1 knockdown analyzed by western blotting. shRNA-1 was used in the 
study. (B) Efficiency of Yme1L knockdown analyzed by western blotting. shRNA-1 was used in 
the study. Actin was used as the loading control. (C) Primers used for analysis of mRNA 
transcripts. Green arrowheads indicate the primers. The forward primer (F) is in exon 3, and the 
reverse primer (R) is in exon 7. Expected sizes for each amplified fragment are listed. 
 
Figure S2.4: Tubulation of mitochondria by isoform 5 mutants. 
(A) Quantification of mitochondrial morphology of Opa1-null MEFs expressing WT or mutant 
FLAG-tagged isoform 5 (mutant 3-9). 100 cells were counted for each experiment. Error bars: 
standard deviation from three independent experiments. (B) Genomic and amino acid sequence 
comparison between mouse Opa1 and human OPA1 exon 4b. Bold letters represent conserved 
sequences between mouse and human, and red letters indicate the exon 4b shRNA-targeted 
sequence. In the amino acid sequence, amino acids in parentheses are encoded partially by the 
adjacent exon.  
 
Figure S2.5: Short form of isoform 5 regulates mitochondrial morphology. 
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(A) Representative images of mitochondrial morphology (mt-Dsred) in Opa1-null MEFs 
expressing isoform 5 and its mutant 10-13 (supplemental for Fig. 5A). Scale bar, 5 m. (B) 
Representative images of mitochondrial morphology (Tom20 immunostaining) in cells shown in 
Fig. 5B. Scale bar, 5 m. (C) Representative images of mitochondrial morphology (Tom20 
immunostaining) in Opa1-null MEFs expressing Iso1-IRES-Iso5 or Iso1-IRES-Iso-5 G300E. 
Scale bar, 5 m. (D) Western blot against OPA1 to confirm the expression of Iso 1-IRES-Iso5 
G300E. HSP60 was used as loading control. (E) Quantification of mitochondrial morphology in 
Opa1-null MEFs expressing Iso 1, Iso1-IRES-Iso5, or Iso1-IRES-Iso5 G300E. Error bars 





Figure S2.1: OPA1 mRNA isoforms and the role of Oma1. 
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This work has demonstrated the following points: 
1. Opa1 is proteolytically cleaved in a novel site by a known protease. 
2. This cleavage is complete under basal conditions whenever exon 4b is present in an 
isoform. 
3. The S3 cleaved isoform alone cannot promote fusion, but together with a long isoform, it 
can enhance mitochondrial tubulation. 
Several key issues still remain to be solved:  
Why would OPA1 need the additional cleavage site? What is the physiological function 
of the S3 site, especially given the fact that the existence of the site can lead to complete OPA1 
processing? What is the structural significance of exon 4b? In comparison with exon 5b, which 
both serve as YME1L recognition sites, a better understanding of the structural difference 
between those two sites will not only enable us to understand OPA1 structure better, but also to 
elucidate more on YME1L’s proteolytic mechanism. 
 
It has been previously well established that OPAl protein has two cleavage sites in the 
main stalk in intermembrane space, generating three different short isoforms. With my study, we 
confirmed with solid evidence that a third cleavage site exists in exon 4b which is present in half 
of the isoforms. Isoforms with exon 4b expression are completely processed into short forms by 
the m-AAA protease YME1l, which is well known to cleave at S2. The complete cleavage seems 
to be quite a strong effect on the protein given that half of the isoforms are completely processed 
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at the site. Why Opa1 has evolved such a complicated cleavage system is not quite well 
understood. The alternative splicing mechanism only exists in higher vertebrates, and may be a 
product of evolution. Therefore, it is not difficult to imagine that the existence of this 
complicated proteolytic processing can be a protective mechanism for Opa1 to maintain a system 
where at least a proportion of OPA1 can be post-translationally processed at at least one site 
under most circumstances, even when the function of one protease gets disrupted or some 
isoforms of Opa1 are not expressed well.  
 
Mgm1, the yeast homolog of Opa1, consists of a GTPase (G) domain, a bundle signaling 
element domain, a stalk, and a paddle domain that contains a membrane-binding site (Faelber et 
al., 2019). Biochemical and cell-based experiments demonstrate that the Mgm1 stalk mediates 
the assembly of bent tetramers into helical filaments. Electron cryo-tomography studies of 
Mgm1-decorated lipid tubes and fluorescence microscopy experiments on reconstituted 
membrane tubes indicate how the tetramers assemble on positively or negatively curved 
membranes (Faelber et al., 2019). Based on these studies, it seems that the membrane 
unassociated s-OPA1 have fusion capability by forming tubes and coordinate with the l-OPA1 to 
pull the inner membrane open.  
 
Selectivity of YME1L proteolytic activity on OPA1 
It is interesting to continue understanding how YME1L can distinguish between S3 and 
S2, especially when both sites are present in one isoform. It remains to be determined why 
inclusion of exon 4b causes such extensive processing by YME1L. A short hydrophobic 
sequence (FAWFP) has been found to act as a degron for YME1L (Shi et al., 2016b). However, 
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no similar sequences are apparent in exon 4b or the rest of OPA1.The exact sequence of S2 site 
is still unknown. Our data suggest that the S2 site exists in the LILL region in exon5b, which is 
also highly enriched in leucines (not published). Based on the similarity of the sequence, it is 
likely that YME1L does not distinguish the site based on sequence. One possibility is the spatial 
location, where YME1L cleaves at the first site it comes across. This is less likely since we know 
that when S3 does not exist, YME1L cleaves at S2 but incompletely, leading to only part of the 
long isoform generating a S2 short form. Whenever exon4b exists in the isoform, Yme1L can 
instead completely cleave the long form all into short forms. Therefore, another more likely 
explanation would be that the structure of exon 4b/S3 provides a better access of Yme1L to the 
Opa1 isoform and somehow facilitates the processing capability. Although recent study reveals a 
partial OPA1 structure starting from the G domain region, the authors suggest that the alternative 
splicing region is predicted to be unstructured and difficult to resolve. Future structural data are 
needed to better understand this mechanism, which will not only help better understand the 
OPA1 processing but also the Yme1L cleavage mechanism, which is a uniquely important inner 
membrane protease known to have multiple substrates on the inner membrane, and may be 
involved in essential cellular functions, proved by the embryonic lethality when knocked out in 
mouse.  
 
Another intriguing question is whether YME1L distinguish between the two sites for 
different functions, in particular responding to various cellular stress. A previous study done in 
our lab suggests that the YME1L cleavage at S2 site is responsive to OXPHOS stress 
stimulation. When cells are forced to do pure OXPHOS to generate ATP (no glycolysis), 
cleavage at S2 gets enhanced and vice versa. When artificially cleaving at S2, mitochondrial 
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inner membrane fusion is induced in vitro (Mishra et al., 2014a). There has been no obvious 
evidence that the S3 serves the same function, as we did observe OXPHOS-induced elongation 
in exon 4b knockdown cells. It is possible that the S3 site can be induced by another stress cue 
and YME1L cleavage can further coordinate according to different environmental stimuli. A 
recent study shows that cells expressing S3 cleaved short isoform only show better survival 
under oxidant insult in OXPHOS media compared to cells with only a non-cleavable long 
isoform 1, which mainly involves necrosis (Lee et al., 2020a). The authors propose a model 
where short Opa1 can cast a protective effect on cell survival under certain stress conditions, 
explaining the pronounced production of short Opa1 when cells are challenged with some 
external stimuli.  
 
Functions of S3 cleaved s-OPA1, fusion vs cristae/OXPHOS maintenance? 
Our findings suggest that this short Opa1 isoform contributes to fusion activity when 
expressed together with a long-form generating isoform. When expressing isoform 5 together 
with isoform 1 in Opa1-null MEFs, the mitochondria are more tubulated compared to those in 
isoform 1 expressing MEFs alone. It seems like this short form exhibits an additive function to 
overall opa1 fusion activity. The persistence of the cleavage events on OPA1 also suggest that 
the production of short OPA1 seem to be fundamental for mitochondria and therefore evolved 
such a well maintained mechanism to keep this process. A previous idea where long form OPA1 
being the functional unit and s-OPA1 is detrimental to cells seems to be inaccurate, as it is not 






The role distinguishing different s-OPA1 forms, if there is any 
It is now clear that the short forms of OPA1 can be roughly categorized into two types—
OMA1-generated short forms and YME1L-generated short forms. In the YME1L generated short 
forms, it is more complicated in terms of actual cleavage site—exon 4b, exon 5b, and when both 
disrupted, potentially in exon 4. The reason why YME1L can recognize and cleave at so many 
different sites remains unknown. With different sizes and N-term residues, it is not known 
whether these different s-OPA1 forms have various functions from each other. It seems unlikely 
that with so few amino acid residue differences, there may be any major physiological function 
change, however, more detailed experiments are still needed to verify this point. Previous results 
from two independent studies have suggested that s-OPA1 seem to share similar functions in 
mtDNA maintenance, cristae structure, etc.   
According to a contradictory result from Ban et al, additional analysis is needed to 
understand the molecular properties of s-OPA1 (e.g., assembly state and orientation), both in 
solution and on the membrane. 
 
Which is more important, absolute or relative amount of s-OPA1? 
It is still not clear whether the absolute amount of OPA1 matters more for fusion and 
other activities, or the relative amount of short compared to long OPA1 is more important.  
 
So far, the model for OPA1 mediated inner membrane fusion seems to be that the GTP 
hydrolysis process functions as a powerful stroke and when hydrolyzed, strongly pull the inner 
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membrane together to facilitate fusion. The GTP hydrolysis activity gets dramatically enhanced 
by interacting with cardiolipin, which is in high concentration on the inner membrane. The 
reason that various in vitro studies suggest that l-OPA1 with cardiolipin alone can promote 
fusion whereas in vivo studies show that the existence of both are needed to complete fusion may 
be explained by the absolute amount needed for mediating fusion. In one study, the authors 
found that with a fixed amount of OPA1, the higher the l-OPA1 content, the more fusion, and 
vice versa. When only the l-OPA1 level is kept constant, the more s-OPA1 was added to the 
reaction (therefore the total amount of OPA1 increases), the more fusion events were observed.  
A structural study revealed that both l- and s-OPA1 can form tetramers and further 
tubulate, as the tubulating domain exists in the middle stalk that is in the middle to C-term end of 
OPA1. When membrane anchored l-Opa1 is enriched, the more free-flowing s-OPA1, the better 
fusion activity it may possess as the free s-OPA1 can freely bind to any l-OPA1 that need to 
tubulate to fuse; however, when the binding gets saturated, the upper limit of fusion gets reached 
and by adding l-Opa1 at the same time, the fusion limit gets uplifted. The difference shown 
between in vivo vs in vitro systems likely resides in the absolute amount of OPA1. In live cells, 
the amount of OPA1 is tightly regulated. At any given time without external stimuli, the amount 
of Opa1 mRNAs and proteins are limited and may not show obvious variations. Therefore, a 
tight regulation of s-OPA1 production is needed to fulfill the need to reach an optimal fusion 
level. If all OPA1 remains as long forms and anchored on the inner membrane, the lack of free 
OPA1 substrate prevents tetramer and tubule formation of the proteins; if excessive s-OPA1 is 
produced, without membrane anchor partner (l-OPA1), the formed free tetramer cannot properly 
bind to the membrane to mediate fusion either.  
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It is important to notice that previous studies and our data all prove that over-expressing 
Opa1 can lead to mitochondrial fragmentation, even with the long form generating isoforms. It is 
possible that a mechanism exists that when OPA1 concentration is too high, fusion activity get 
inhibited. It can be a mechanism where the inner membrane protects from fusing with each other, 
especially in cristae junction regions where Opa1 can exist on opposing sides of the same inner 
membrane.  
 
An interesting new study done by Ge et al. established an in vitro assay to visualize the 
inner membrane fusion more closely on a single event basis. In their study, they further broke 
down one single inner membrane fusion process into four steps: membrane tethering, docking, 
hemifusion, and pore opening. They found that while both l- and s-OPA1 can complete the first 
tethering step, where membranes are brought into close proximity, only l-OPA1 can further 
mediate the docking step, where tethered membranes are brought into extremely close distance 
(FRET distance, <40-60 A) and ready to progress into fusion (Ge et al., 2020). Furthermore, l-
OPA1 on a heterotypic membrane (in this case, only one membrane is anchored with l-OPA1 
protein and the other is free of OPA1) can progress further into lipid bilayer hemifusion, 
however, the efficiency of hemifusion is at least 3-folds lower compared to that of l-OPA1 on a 
homotypic membrane (l-OPA1 expressed on both lipid bilayers). The final step of fusion is pore 
opening and content release, where both leaflets merge. The authors found that about half of the 
particles undergoing hemifusion can proceed to pore opening (Ge et al., 2020). S-OPA1 labeled 
particles or heterotypic l-OPA1 particles do not show pore opening or content mixing. Equimolar 
addition of s-OPA1 into the l-OPA1 homotypic particle system increases the pore opening 
efficiency by at least eight-fold and decreases the dwell time by four-fold. Excessive s-OPA1 
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have a dominant negative effect to this process and have been shown to facilitate vesicle 
detachment of the l-OPA1 particles.  
 
The interplay between OPA1 and mitochondrial permeability transition 
Mitochondrial permeability transition is an alteration in mitochondrial inner membrane 
permeability, which is usually highly nonpermeable. It is thought to be the strategic regulator of 
cell death when first discovered (Crompton and Costi, 1990), and can be induced by Ca2+ as well 
as oxidative stress (Takeyama et al., 1993). 
A recent study on OPA1 short isoform showed that when cells are supplemented with 
only short OPA1, they can decrease the sensitivity of MPT, leading to a ‘protective’ effect on 
cells under oxidative insults (Lee et al., 2020a). The opposite effect was seen with cells 
expressing solely exogenous l-OPA1, which sensitize the cells under oxidative stress and which 
results in early membrane permeability collapse. This new finding opens up the path to think 
possible additional roles of OPA1 besides mediating fusion and cristae remodeling, and extends 
the level of the OPA1 function to a broader scheme within the mitochondrial microenvironment. 
However, the researchers were not able to elucidate the pathway that OPA1 may be playing a 
role in, and the functional partner (if any) of OPA1. The here introduced in vivo model of l- and 
s-OPA1 isoforms and their combination would be able to test this MPT sensitization function of 
endogenous OPA1 under various stress conditions, and further study the link between OPA1 and 
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